<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">90025</article-id>
<article-id pub-id-type="doi">10.7554/eLife.90025</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.90025.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Developmental Biology</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Deciphering the genetic interactions between Pou4f3, Gfi1 and Rbm24 in maintaining cochlear hair cell survival</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Guangqin</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gu</surname>
<given-names>Yunpeng</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9675-1233</contrib-id>
<name>
<surname>Liu</surname>
<given-names>Zhiyong</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences</institution>, Shanghai, 200031, <country>China</country></aff>
<aff id="a2"><label>2</label><institution>University of Chinese Academy of Sciences</institution>, Beijing, 100049, <country>China</country></aff>
<aff id="a3"><label>3</label><institution>Shanghai Center for Brain Science and Brain-Inspired Intelligence Technology</institution>, Shanghai, 201210, <country>China</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Whitfield</surname>
<given-names>Tanya T</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Sheffield</institution>
</institution-wrap>
<city>Sheffield</city>
<country>United Kingdom</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Cheah</surname>
<given-names>Kathryn Song Eng</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>University of Hong Kong</institution>
</institution-wrap>
<city>Hong Kong</city>
<country>Hong Kong</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Corresponding authors: Dr. Zhiyong Liu; E-mail: <email>Zhiyongliu@ion.ac.cn</email> Tel: 0086-21-54921793 (Office)</corresp>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2023-07-25">
<day>25</day>
<month>07</month>
<year>2023</year>
</pub-date>
<volume>12</volume>
<elocation-id>RP90025</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-06-14">
<day>14</day>
<month>06</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-06-22">
<day>22</day>
<month>06</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.06.22.546097"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2023, Wang et al</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Wang et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-90025-v1.pdf"/>
<abstract>
<title>Abstract</title><p>Mammals have limited sound receptor hair cells (HCs) that cannot be regenerated after damage. Thus, investigating the molecular mechanisms underlying how to maintain HC survival is crucial to prevent hearing impairment. The <italic>Pou4f3<sup>-/-</sup></italic>or <italic>Gfi1<sup>-/-</sup></italic> HCs initially form but rapidly degenerate, whereas <italic>Rbm24<sup>-/-</sup></italic> HCs degenerate much later. It remains elusive about the transcriptional cascades among Pou4f3, Gfi1 and Rbm24. Here, we demonstrate that <italic>Rbm24</italic> expression is completely repressed in <italic>Pou4f3<sup>-/-</sup></italic> HCs, but its expression is not altered in <italic>Gfi1<sup>-/-</sup></italic>HCs. Moreover, both Pou4f3 and Gfi1 expressions are intact in <italic>Rbm24<sup>-/-</sup></italic>HCs. Moreover, by the <italic>in vivo</italic> mouse transgenic reporter assays, we identify three <italic>Rbm24</italic> enhancers to which Pou4f3 binds. Finally, we test whether Rbm24 restoration can alleviate degeneration of <italic>Pou4f3<sup>-/-</sup></italic> HCs. Our <italic>in vivo</italic> genetic assay shows that ectopic Rbm24 alone is unable to stop <italic>Pou4f3<sup>-/-</sup></italic> HCs from undergoing degeneration. Collectively, our study provides new molecular and genetic insights into how HC survival is regulated.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Key words</title>
<kwd>Pou4f3</kwd>
<kwd>Gfi1</kwd>
<kwd>Rbm24</kwd>
<kwd>hair cells</kwd>
<kwd>cochlea</kwd>
</kwd-group>

</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Housed in the mammalian cochlea, the auditory epithelium, also referred to as the Organ of Corti (OC), contains the mechanosensory receptors hair cells (HCs) that detect sound information <sup><xref ref-type="bibr" rid="c1">1</xref>, <xref ref-type="bibr" rid="c2">2</xref></sup>. Two types of HCs exist: inner HCs (IHCs) and outer HCs (OHCs), with one row of IHCs and three rows of OHCs <sup><xref ref-type="bibr" rid="c3">3</xref></sup>. OHCs and IHCs derive from the cochlear progenitors experiencing high level of Atoh1, a master transcription factor (TF) in HC development <sup><xref ref-type="bibr" rid="c4">4</xref>–<xref ref-type="bibr" rid="c6">6</xref></sup>. No HCs are formed in <italic>Atoh1 <sup>-/-</sup></italic> cochleae, highlighting the essential roles of Atoh1 in specifying the general HC fates in the undifferentiated progenitors <sup><xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c8">8</xref></sup>. OHCs uniquely express motor protein Prestin (encoded by <italic>Slc26a5</italic>) and serve as sound amplifiers <sup><xref ref-type="bibr" rid="c9">9</xref>, <xref ref-type="bibr" rid="c10">10</xref></sup>. In contrast, IHCs specifically express Fgf8, vGlut3 (encoded by <italic>Slc17a8</italic>) and Otoferlin <sup><xref ref-type="bibr" rid="c11">11</xref>–<xref ref-type="bibr" rid="c15">15</xref></sup>, acting as the primary sensory cells that form synapses with different subtypes of type I spiral (auditory) neurons <sup><xref ref-type="bibr" rid="c16">16</xref>–<xref ref-type="bibr" rid="c19">19</xref></sup>. Insm1 is necessary in stabilizing OHC fate, and ∼50% of <italic>Insm1<sup>-/-</sup></italic> OHCs tend to transdifferentiate into IHC-like cells <sup><xref ref-type="bibr" rid="c20">20</xref>, <xref ref-type="bibr" rid="c21">21</xref></sup>. Ikzf2 is not needed in early OHC development but is required in consolidating the OHC fate, and <italic>Ikzf2 <sup>cello/cello</sup></italic> deficient OHCs are dysfunctional and misexpress IHC genes <sup><xref ref-type="bibr" rid="c22">22</xref></sup>. Insm1 is an epistatic but indirect positive regulator of Ikzf2, and restoration of Ikzf2 can partially mitigate the phenotypes of <italic>Insm1<sup>-/-</sup></italic> OHCs <sup><xref ref-type="bibr" rid="c21">21</xref></sup>. In contrast to Insm1 and Ikzf2, Tbx2 is required in IHC fate specification, differentiation, and maintenance, and IHC to OHC conversion occurs in the absence of Tbx2 <sup><xref ref-type="bibr" rid="c23">23</xref>–<xref ref-type="bibr" rid="c25">25</xref></sup>.</p>
<p>It is necessary to maintain the survival of cochlear HCs after their production. Pou4f3, a POU-domain family TF and known hearing loss gene (DFNA15), is essential for HCs to survive <sup><xref ref-type="bibr" rid="c26">26</xref>–<xref ref-type="bibr" rid="c30">30</xref></sup>. Different from Atoh1, Pou4f3 is not involved in fate determination of HCs <sup><xref ref-type="bibr" rid="c31">31</xref></sup>. As one target gene regulated by Atoh1 <sup><xref ref-type="bibr" rid="c27">27</xref>, <xref ref-type="bibr" rid="c32">32</xref></sup>, <italic>Pou4f3</italic> is turned on in HCs between E14.5 and E16 in a basal to apical gradient, and subsequently Pou4f3 activates <italic>Gfi1,</italic> another zinc finger TF <sup><xref ref-type="bibr" rid="c33">33</xref>, <xref ref-type="bibr" rid="c34">34</xref></sup>. Gfi1 becomes undetectable in <italic>Pou4f3</italic>-deficient HCs <sup><xref ref-type="bibr" rid="c34">34</xref></sup>. HCs, especially the OHCs, degenerate in <italic>Pou4f3</italic> and <italic>Gfi1</italic>-mutants by birth <sup><xref ref-type="bibr" rid="c34">34</xref></sup>. Besides Pou4f3 and Gfi1, RNA binding protein Rbm24 is also specifically expressed in cochlear HCs <sup><xref ref-type="bibr" rid="c35">35</xref></sup>. Our recent study shows that Rbm24 is indispensable in maintaining the survival of OHCs, but the OHC death happens much later than the case in <italic>Pou4f3</italic> and <italic>Gfi1</italic>-mutants, with OHCs develop normally by birth but the majority of them undergo cell death by postnatal day 19 (P19) in <italic>Rbm24<sup>-/-</sup></italic> mice <sup><xref ref-type="bibr" rid="c36">36</xref></sup>. It remains elusive about how <italic>Rbm24</italic> is regulated during cochlear HC development.</p>
<p>The similar but delayed phenotype of OHC death in <italic>Rbm24</italic> mutants relative to <italic>Pou4f3</italic> and <italic>Gfi1</italic>-deficient mice prompted us to dissect the potential genetic interactions among them by utilizing <italic>in vivo</italic> genetic approach. Our data clearly showed that onset of Rbm24 expression was completely repressed in <italic>Pou4f3<sup>-/-</sup></italic> HCs. Surprisingly, Rbm24 expression was normal in <italic>Gfi1<sup>-/-</sup></italic> HCs. Moreover, neither Pou4f3 nor Gfi1 expression was altered in the <italic>Rbm24<sup>-/-</sup></italic> HCs. Thus, our data showed that Pou4f3, but not Gfi1, is required in <italic>Rbm24</italic> expression. Furthermore, we identified three <italic>Rbm24</italic> enhancers that were sufficient to drive specific EGFP reporter expression in HCs, which are likely bound by Pou4f3. Finally, restoration of Rbm24 alone cannot alleviate the degeneration of <italic>Pou4f3<sup>-/-</sup></italic> HCs, highlighting that additional targeted genes of Pou4f3 are needed to be restored before keeping <italic>Pou4f4<sup>-/-</sup></italic>HCs able to survive. In sum, our study provides new insights into the genetic interactions among Pou4f3, Gfi1 and Rbm24, with potential applications into HC protection.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Rbm24 expression is completely repressed in <italic>Pou4f3 <sup>-/-</sup></italic> cochlear HCs</title>
<p>HC degeneration happens in both <italic>Pou4f3<sup>-/-</sup></italic> and <italic>Rbm24<sup>-/-</sup></italic> mice, with the phenotypes occur earlier and are more severe in <italic>Pou4f3<sup>-/-</sup></italic> mice <sup><xref ref-type="bibr" rid="c34">34</xref>, <xref ref-type="bibr" rid="c36">36</xref></sup>. It prompted us to speculate that genetic interaction between <italic>Pou4f3</italic> and <italic>Rbm24</italic> exists. Given Pou4f3 is the upstream positive regulator of Rbm24, Rbm24 expression should be blocked in the absence of Pou4f3. To rapidly determine whether it is the case, we took advantage of our previously established CRISPR-stop approach <sup><xref ref-type="bibr" rid="c37">37</xref></sup>. As illustrated in <xref ref-type="fig" rid="figs1">Supplemental Figure 1A</xref>, co-injecting one sgRNA-1 against <italic>Pou4f3</italic> and base editor components in one-cell stage mouse zygotes yielded founder 0 (F0) mice whose tail DNA was subjected to sanger sequencing. Relative to wild type (WT) mice (<xref ref-type="fig" rid="figs1">Supplemental Figure 1B</xref>), the F0 mice carrying the homozygous premature emergence of stop codon (TAG) were defined as <italic>Pou4f3<sup>-/-</sup></italic>mice that were immediately ready for phenotypic analysis (<xref ref-type="fig" rid="figs1">Supplemental Figure 1C</xref>).</p>
<p>Triple staining of Pou4f3, Rbm24 and Insm1 demonstrated that OHCs were Pou4f3+/Rbm24+/Insm1+, and IHCs expressed Pou4f3 and Rbm24, but not Insm1 in basal turn of WT mice at E16.5 (n=3, <xref rid="figs1" ref-type="fig">Supplemental Figure 1D-D</xref>’’’). Pou4f3 expression was completely absent in the <italic>Pou4f3 <sup>-/-</sup></italic> mice (n=9, <xref rid="figs1" ref-type="fig">Supplemental Figure 1E-E</xref>’’’), confirming that Pou4f3 translation was blocked. Different from WT mice, Rbm24 expression completely disappeared in the <italic>Pou4f3 <sup>-/-</sup></italic> mice at E16.5 (<xref rid="figs1" ref-type="fig">Supplemental Figure 1E-E</xref>’’’). Notably, Insm1 expression seemed normal in <italic>Pou4f3 <sup>-/-</sup></italic> mice (arrows in <xref rid="figs1" ref-type="fig">Supplemental Figure 1E-E</xref>’’’), although we noticed that the alignment of Insm1+ OHCs was not as regular as the WT OHCs (<xref rid="figs1" ref-type="fig">Supplemental Figure 1D-D</xref>’’’). Moreover, the presence of Insm1+ OHCs in the <italic>Pou4f3 <sup>-/-</sup></italic> mice ruled out the possibility that the absence of Rbm24 was due to a secondary effect of OHC death or delayed differentiation, and also agreed with previous report that initial HC differentiation can occur without Pou4f3 <sup><xref ref-type="bibr" rid="c31">31</xref>, <xref ref-type="bibr" rid="c34">34</xref></sup>. Thus, the rapid <italic>Pou4f3</italic> loss-of-function analysis by CRISPR-stop supports our hypothesis that Pou4f3 is required in turning on Rbm24 expression.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Rbm24 expression is repressed in cochlear HCs in the absence of Pou4f3.</title>
<p><bold>(A)</bold> A simple illustration of how <italic>Pou4f3 <sup>-/-</sup></italic> strain was generated. <bold>(B)</bold> One exampled tail PCR gel image that helped us to distinguish WT (<italic>Pou4f3<sup>+/+</sup></italic>), heterozygous (<italic>Pou4f3<sup>+/-</sup></italic>) and homozygous (<italic>Pou4f3<sup>-/-</sup></italic>) mice. <bold>(C-F’’’)</bold> Triple straining of Rbm24, Pou4f3 and Bcl11b in WT (C and E-E’’’) and <italic>Pou4f3<sup>-/-</sup></italic> (D and F-F’’’) mice (n=3 for each) at E16.5, with only Rbm24 (green) channel was visualized in (C and D) at low magnification. (E-E’’’) and (F-F’’’) were the high magnification images of middle turn WT and <italic>Pou4f3<sup>-/-</sup></italic> mice, respectively. In the absence of Pou4f3, Rbm24 expression completely disappeared, despite nascent Bcl11b+ OHCs were present. OHC: outer hair cell; IHC: inner hair cell. Scale bars: 100 μm (D), 20 μm (F’’’).</p></caption>
<graphic xlink:href="546097v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To further validate the observation above, we also constructed a germ line stable <italic>Pou4f3</italic> mutants in which the entire Pou4f3 genome between sgRNA-2 and sgRNA-3 was deleted (<xref rid="fig1" ref-type="fig">Figure 1A</xref>). The three genotypes of <italic>Pou4f3<sup>+/+</sup></italic>, <italic>Pou4f3<sup>+/-</sup></italic> and <italic>Pou4f3<sup>-/-</sup></italic> were readily distinguished by tail DNA PCR (<xref rid="fig1" ref-type="fig">Figure 1B</xref>). Relative to WT mice (n=3, <xref rid="fig1" ref-type="fig">Figure 1C</xref>), Rbm24 again was completely absent in <italic>Pou4f3<sup>-/-</sup></italic> mice at E16.5 (n=3, <xref rid="fig1" ref-type="fig">Figure 1D</xref>). Like Insm1, Bcl11b is another OHC marker <sup><xref ref-type="bibr" rid="c20">20</xref></sup>. Triple staining of Rbm24, Pou4f3 and Bcl11b also demonstrated that, relative to WT HCs (<xref rid="fig1" ref-type="fig">Figure 1E-E</xref>’’’), Rbm24 was completely absent in <italic>Pou4f3<sup>-/-</sup></italic> HCs (<xref rid="fig1" ref-type="fig">Figure 1F-F</xref>’’’). Presence of Bcl11b+ OHCs also confirmed that production of nascent OHCs were normal in the absence of Pou4f3. Moreover, in contrast to WT mice at P1 (n=3, <xref rid="figs2" ref-type="fig">Supplemental Figure 2A-A</xref>’’), HC degeneration was manifest in the germ line <italic>Pou4f3<sup>-/-</sup></italic> mutants at P0 (n=4, <xref rid="figs2" ref-type="fig">Supplemental Figure 2B-B</xref>’’) and P1 (n=3, <xref ref-type="fig" rid="figs2">Supplemental Figure 2C-C</xref>’’). By normalizing numbers of the remaining HCs in <italic>Pou4f3<sup>-/-</sup></italic>mice at P0 or P1 to those in WT mice at P1, we found that in P0 <italic>Pou4f3<sup>-/-</sup></italic> mice, 35.94% ± 4.52%, 38.16% ± 2.79% and 63.8% ± 5.28% HCs survived in basal, middle and apical turns, respectively. However, in P1 <italic>Pou4f3<sup>-/-</sup></italic>mice, 5.54% ± 3.11%, 15.79% ± 3.65% and 65.64% ± 7.95% of the HCs respectively survived in basal, middle and apical turns. Thus, HC degeneration at middle and basal turns was more severe (** p&lt;0.01) at P1 than that at P0, but there was no significant difference in apical turns (<xref rid="figs2" ref-type="fig">Supplemental Figure 2D</xref>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Gfi1 is dispensable for Rbm24 expression.</title>
<p><bold>(A)</bold> A simple cartoon representing how the <italic>Gfi1</italic> was inactivated in the one-cell stage mouse zygotes derived from male <italic>Gfi1<sup>HACre/+</sup></italic> by the CRISPR-stop approach. <bold>(B-C)</bold> With sgRNA-6 as an example, the Sanger sequencing chromatograms of control <italic>Gfi1<sup>HACre/+</sup></italic> (B) and F0 <italic>Gfi1<sup>-/-</sup></italic> (C) were presented. The base ‘C’ (black arrow in B) was converted in ‘T’ (red arrow in C), resulting in pre-emergence of protein translation stop codon TAG. The red ‘T’ was a single peak, meaning that the pre-emergence of stop codon occurred in both alleles. <bold>(D-E’’)</bold> Dual staining of HA (Gfi1) and Rbm24 in cochleae from control <italic>Gfi1<sup>HACre/+</sup></italic>(D-D’’, n=3) and F0 <italic>Gfi1<sup>-/-</sup></italic> (E-E’’) mice (n=4) at E16.5. Rbm24 expression (E’) was not altered in the absence of the HA (Gfi1) expression (E). OHC: outer hair cell; IHC: inner hair cell. Scale bar: 20 μm.</p></caption>
<graphic xlink:href="546097v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Different from WT cochleae in which all Myo7a+ HCs expressed Rbm24 (<xref rid="figs2" ref-type="fig">Supplemental Figure 2E-E</xref>’’), in <italic>Pou4f3<sup>-/-</sup></italic> cochleae the remaining HCs lost Rbm24 expression (arrows in <xref rid="figs2" ref-type="fig">Supplemental Figure 2F-F</xref>’’). Collectively, our data from two different <italic>Pou4f3-</italic>deficient models support that Pou4f3 is indispensable for turning on <italic>Rbm24</italic>. Nonetheless, whether Gfi1 is also essential for Rbm24 expression remains to be determined.</p>
</sec>
<sec id="s2b">
<title>Construction of a <italic>Gfi1-3× HA-P2A-Cre/+</italic> knockin mouse strain</title>
<p>We determined whether the regulation of <italic>Rbm24</italic> by Pou4f3 through Gfi1 or independently of Gfi1. Due to lack of a good commercial Gfi1 antibody suitable for immunostaining, we decided to construct a <italic>Gfi1-3× HA-P2A-Cre/+</italic> (<italic>Gfi1<sup>HA-Cre/+</sup></italic> in brief) knockin mouse strain via our routine CRISPR/Cas9 approach (<xref rid="figs3" ref-type="fig">Supplemental Figure 3A-C</xref>). In principle, the C-terminus of Gfi1 was tagged with three HA fragments, and the Cre is under the endogenous <italic>cis</italic>-regulatory elements of <italic>Gfi1</italic>. The WT (<italic>Gfi1<sup>+/+</sup></italic>), heterozygous (<italic>Gfi1<sup>HA-Cre/+</sup></italic>) and homozygous (<italic>Gfi1<sup>HA-Cre/HA-Cre</sup></italic>) mice were readily distinguished by tail PCR (<xref ref-type="fig" rid="figs3">Supplemental Figure 3D</xref>). In addition to the <italic>Gfi1</italic> locus, Southern blot assay showed that random insertion of the targeting vector (<xref ref-type="fig" rid="figs3">Supplemental Figure 3B</xref>) happened in the unknown genomic region. Nonetheless, it was likely that the random insertion happened in a silent genomic region, which was evidenced by the analysis below.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Pou4f3 and Gfi1 expressions are normal in the absence of <italic>Rbm24</italic>.</title>
<p><bold>(A)</bold> A simple cartoon to elaborate how we used CRISPR-stop approach to induce mosaic inactivation of Rbm24 in the one-cell stage mouse zygote harboring <italic>Gfi1<sup>HACre/+</sup></italic>. Notably, the injection was in the late one-cell stage of the zygotes, resulting in higher rates of final mosaic inactivation. <bold>(B-C)</bold> The Sanger sequencing chromatograms of control <italic>Gfi1<sup>HACre/+</sup>; Rbm24<sup>+/+</sup></italic> (B) and <italic>Gfi1<sup>HACre/+</sup>; Rbm24<sup>-/-</sup></italic> (mosaic) (C). The base ‘C’ (black arrow in B) was converted into ‘T’ (red arrow in C) in a fraction of cochlear cells. Notably, the mosaic inactivation of Rbm24 was evidenced by the double peaks of ‘T’ and ‘C’ (red arrow in C). <bold>(D-E’’’)</bold> Triple staining of Rbm24, HA and Pou4f3 in cochlear samples (basal turns) of control <italic>Gfi1<sup>HACre/+</sup>; Rbm24<sup>+/+</sup></italic>(D-D’’’, n=3) and <italic>Gfi1<sup>HACre/+</sup>; Rbm24<sup>-/-</sup></italic> (mosaic) (E-E’’’, n=3) at E17. Consistent with the Sanger sequencing results (C), Rbm24 was inactivated in cochlear HCs in a mosaic pattern (E). The orange arrows (E-E’’’) pointed to one OHC that lost Rbm24, whereas the blue arrows (E-E’’’) marked one OHC in which the Rbm24 expression was maintained. Notably, regardless of whether Rbm24 was inactivated or not, HA (Gfi1) and Pou4f3 expression were not altered. OHC: outer hair cell; IHC: inner hair cell. Scale bar: 20 μm (E’’’).</p></caption>
<graphic xlink:href="546097v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Dual staining of HA (Gfi1) and pan-HC marker Myo7a demonstrated that, similar to <italic>Gfi1<sup>+/+</sup></italic> mice (n=3, <xref ref-type="fig" rid="figs3">Supplemental Figure 3E-E</xref>’’), HC development in <italic>Gfi1<sup>HA-Cre/HA-Cre</sup></italic> was normal at P1 (n=3, <xref rid="figs3" ref-type="fig">Supplemental Figure 3F-F</xref>’’). Moreover, HA (Gfi1) was highly expressed in all Myo7a+ IHCs and OHCs in <italic>Gfi1<sup>HA-Cre/HA-Cre</sup></italic> mice (arrows in <xref rid="figs3" ref-type="fig">Supplemental Figure 3F-F</xref>’’). It confirmed that Gfi1 endogenous expression is not affected in the <italic>Gfi1<sup>HA-Cre/HA-Cre</sup></italic> mice, representing an advantage over the previous <italic>Gfi1<sup>Cre/+</sup></italic> strain where one copy of <italic>Gfi1</italic> is lost and early onset of hearing loss happens in <italic>Gfi1<sup>Cre/+</sup></italic> <sup><xref ref-type="bibr" rid="c38">38</xref>, <xref ref-type="bibr" rid="c39">39</xref></sup>.</p>
<p>We additionally performed the fate mapping analysis of <italic>Gfi1<sup>HA-Cre/+</sup>; Rosa26-loxp-stop-loxp-tdTomato (</italic>Ai9<italic>)/+</italic> (<italic>Gfi1<sup>HA-Cre/+</sup></italic>; Ai9/+) at P2. The <italic>Gfi1<sup>HA-Cre/+</sup>;</italic> Ai9<italic>/+</italic> model allowed us to both visualize temporal Gfi1 protein expression pattern and permanently mark cells experiencing <italic>Gfi1</italic> expression with tdTomato. Neither tdTomato nor HA was detected in the Myo7a+ HCs of the control Ai9/+ mice (n=5, <xref rid="figs3" ref-type="fig">Supplemental Figure 3G-G</xref>’’’ and <xref ref-type="fig" rid="figs3">I-I</xref>’’). In contrast, majority of the Myo7a+ HCs expressed tdTomato and HA in the <italic>Gfi1<sup>HA-Cre/+</sup>;</italic> Ai9<italic>/+</italic> mice (n=5, <xref rid="figs3" ref-type="fig">Supplemental Figure 3H-H</xref>’’’ and <xref ref-type="fig" rid="figs3">J-J</xref>’’). We noticed that the general HA (Gfi1) expression level in IHCs seemed higher than that in OHCs (<xref rid="figs3" ref-type="fig">Supplemental Figure 3J-J</xref>’’). Moreover, HA (Gfi1) expression levels exhibited manifest heterogeneities among OHCs. The OHCs expressing the highest (#1), intermediate (#2) and lowest (#3) levels of HA (Gfi1) were respectively marked (arrows in <xref rid="figs3" ref-type="fig">Supplemental Figure 3J-J</xref>’’). Notably, such a heterogenous Gfi1 expression in neonatal HCs was not observed in <italic>Gfi1<sup>HA-Cre/HA-Cre</sup></italic> mice (<xref rid="figs3" ref-type="fig">Supplemental Figure 3F-F</xref>’’), likely due to the higher level of HA tagged Gfi1 in <italic>Gfi1<sup>HA-Cre/HA-Cre</sup></italic> than in <italic>Gfi1<sup>HA-Cre/+</sup></italic> mice. Besides HCs, tdTomato+ cells were present in the non-sensory regions (arrows in <xref rid="figs3" ref-type="fig">Supplemental Figure 3H</xref>), consistent with the previous report <sup><xref ref-type="bibr" rid="c38">38</xref></sup>. Collectively, <italic>Gfi1<sup>HA-Cre/+</sup></italic> strain was suitable to visualize Gfi1 protein by HA antibody, albeit random insertion of the targeting vector existed. Alternatively, <italic>Gfi1<sup>HA-Cre/+</sup></italic> at least can be treated as a pseudo transgenic mouse strain, by which we can reliably visualize Gfi1 and trace cells experiencing <italic>Gfi1</italic> expression.</p>
</sec>
<sec id="s2c">
<title>Gfi1 expression is prohibited in the <italic>Pou4f3<sup>-/-</sup></italic> cochlear HCs</title>
<p>Given HA can faithfully represent the Gfi1 expression in the <italic>Gfi1<sup>HA-Cre/+</sup></italic>, HA expression was expected to be repressed in the <italic>Pou4f3<sup>-/-</sup></italic> HCs, as reported by previous studies <sup><xref ref-type="bibr" rid="c33">33</xref>, <xref ref-type="bibr" rid="c34">34</xref></sup>. We confirmed this predication by our CRISPR-stop approach <sup><xref ref-type="bibr" rid="c37">37</xref></sup>. Basically, the pipeline was identical to the production of <italic>Pou4f3</italic> mutants described above (<xref ref-type="fig" rid="figs1">Supplemental Figure 1</xref>), except that here the zygotes were derived from male <italic>Gfi1<sup>HA-Cre/+</sup></italic> mice (<xref rid="figs4" ref-type="fig">Supplemental Figure 4A</xref>). We obtained the mosaic (or chimeric) <italic>Pou4f3<sup>-/-</sup></italic> mice, which was confirmed by Sanger sequencing of tail PCR (<xref rid="figs4" ref-type="fig">Supplemental Figure 4B</xref> and <xref ref-type="fig" rid="figs4">C</xref>), partly due to the injection time was the late stage of one-cell stage zygotes. In control <italic>Gfi1<sup>HA-Cre/+</sup></italic> mice, there was a pure ‘C’ base (blue arrow in <xref ref-type="fig" rid="figs4">Supplemental Figure 4B</xref>), however, a mixture of ‘C’ and ‘T’ double peaks existed in <italic>Gfi1<sup>HA-Cre/+</sup>; Pou4f3<sup>-/-</sup></italic> (mosaic) mice (red arrow in <xref ref-type="fig" rid="figs4">Supplemental Figure 4C</xref>). Nonetheless, the advantage of the mosaic <italic>Pou4f3<sup>-/-</sup></italic> mice was that it allowed us to have internal control <italic>Pou4f3<sup>+/+</sup></italic> and <italic>Pou4f3<sup>-/-</sup></italic> HCs in the same cochlea, and to determine the phenotype occurs in a cell autonomous or non-cell autonomous manner.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Three <italic>Rbm24</italic> enhancers are sufficient to drive specific EGFP expression in cochlear HCs.</title>
<p><bold>(A)</bold> Visualization of ATAC-seq (top row, orange color) of P1 cochlear HCs (from our previous study, GSE181311) and Pou4f3 Cut&amp;Run assay (bottom row, blue color) of E17.5 cochlear HCs (from another study, GSE150391) by Integrative Genomics Viewer. The black arrow marked the <italic>Rbm24</italic> promoter, and the three <italic>Rbm24</italic> enhancers (Eh1, Eh2 and Eh3) were marked by the dotted square. <bold>(B-G’’)</bold> Dual staining of EGFP and Myo7a in Eh1-EGFP+ (B-C’’, n=7), Eh2-EGFP+ (D-E’’, n=6) and Eh3-EGFP+ (F-G’’, n=4) at P1. Only the EGFP channel was visualized in whole mount staining (B, D, F). In the cryosection cochlear samples, EGFP was overlapped with HC marker Myo7a. OHCs: outer hair cells; IHC: inner hair cell. Scale bars: 100 μm (F), 20 μm (G’’).</p></caption>
<graphic xlink:href="546097v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>In control <italic>Gfi1<sup>HA-Cre/+</sup></italic> mice (n=3) at E16.5, all HCs expressed Pou4f3, Rbm24 and HA(Gfi1), albeit HA (Gfi1) levels again seemed heterogenous among the OHCs (<xref rid="figs4" ref-type="fig">Supplemental Figure 4D-D</xref>’’’). In contrast, in the <italic>Gfi1<sup>HA-Cre/+</sup></italic>; <italic>Pou4f3<sup>-/-</sup></italic> (mosaic) mice (n=3), we captured HCs that lost or maintained Pou4f3 expression (<xref rid="figs4" ref-type="fig">Supplemental Figure 4E-E</xref>’’’). Notably, Pou4f3+ HCs expressed HA(Gfi1) and Rbm24 (blue arrows in <xref rid="figs4" ref-type="fig">Supplemental Figure 4E-E</xref>’’’), in contrast, both HA(Gfi1) and Rbm24 disappeared in HCs that lost Pou4f3 expression (orange arrows in <xref rid="figs4" ref-type="fig">Supplemental Figure 4E-E</xref>’’’). Thus, our data clearly confirmed that HA indeed was a reliable readout for Gfi1 expression and was sensitive to loss of Pou4f3. Moreover, it supported that Pou4f3 regulates <italic>Rbm24</italic> in a cell autonomous manner.</p>
</sec>
<sec id="s2d">
<title>Gfi1 is dispensable for Rbm24 expression</title>
<p>Next, we produced <italic>Gfi1<sup>-/-</sup></italic> mutants by the same CRISPR-stop approach <sup><xref ref-type="bibr" rid="c37">37</xref></sup>. One-cell stage zygotes derived from male <italic>Gfi1<sup>HA-Cre/+</sup></italic> mice were injected with base editor components and 4 different sgRNAs located in different exons of <italic>Gfi1</italic> (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). The reason why 4 sgRNAs were combined was elaborated in the discussion part. With sgRNA-6 as an example, Sanger sequencing of tail DNA demonstrated that, relative to control <italic>Gfi1<sup>HA-Cre/+</sup></italic> mice (black arrow in <xref rid="fig2" ref-type="fig">Figure 2B</xref>), premature emergence of TAG stop codon happened in F0 mice, resulting in homozygous Gfi1 inactivation (red arrow in <xref rid="fig2" ref-type="fig">Figure 2C</xref>). All HCs expressed HA (Gfi1) and Rbm24 in control <italic>Gfi1<sup>HA-Cre/+</sup></italic> mice (n=3, <xref rid="fig2" ref-type="fig">Figure 2D-D</xref>’’). Notably, Rbm24 expression was maintained in the <italic>Gfi1<sup>-/-</sup></italic> HCs that lost HA (Gfi1) at E16.5 (n=4, <xref rid="fig2" ref-type="fig">Figure 2E-E</xref>’’). It suggested that Rbm24 expression is not dependent on Gfi1.</p>
<p>The advantage of the above <italic>Gfi1<sup>-/-</sup></italic> model was rapid and direct confirming the absence of Gfi1 expression in the F0 mice. However, we cannot guarantee that all HCs completely lost Gfi1 expression at the single cell resolution via HA staining, because only one allele of Gfi1 was <italic>Gfi1<sup>HA-Cre</sup></italic>. Thus, to rule out the possibility that only the HA tagged Gfi1 allele was mutated, we further generated the germ line stable <italic>Gfi1</italic> mutants in which its majority DNA fragments between sgRNA-4 and sgRNA-9 were deleted (<xref ref-type="fig" rid="figs5">Supplemental Figure 5A</xref>). The WT (<italic>Gfi1<sup>+/+</sup></italic>), <italic>Gfi1<sup>+/-</sup></italic> and <italic>Gfi1<sup>-/-</sup></italic> mice were readily to be identified by tail PCR (<xref ref-type="fig" rid="figs5">Supplemental Figure 5B</xref>). Consistent with previous reports <sup><xref ref-type="bibr" rid="c40">40</xref></sup>, dual staining of Rbm24 and Pou4f3 showed that, relative to WT mice (n=3, <xref rid="figs5" ref-type="fig">Supplemental Figure 5C-C</xref>’’), severe degeneration of HCs, especially of the OHCs, was present in the <italic>Gfi1<sup>-/-</sup></italic> mice (n=3, <xref rid="figs5" ref-type="fig">Supplemental Figure 5D-D</xref>’’). It validated the success of generating the <italic>Gfi1<sup>-/-</sup></italic> mice. Notably, the surviving Pou4f3+ HCs kept the expression of Rbm24 (orange arrows in <xref rid="figs5" ref-type="fig">Supplemental Figure 5D-D</xref>’’). In contrast, no significant difference was observed between WT and <italic>Gfi1<sup>-/-</sup></italic> mice at E16.5, as both WT and <italic>Gfi1<sup>-/-</sup></italic>HCs expressed Pou4f3 and Rbm24, and both WT and <italic>Gfi1<sup>-/-</sup></italic> OHCs expressed Bcl11b (<xref rid="figs5" ref-type="fig">Supplemental Figure 5E-F</xref>’’’). It suggests that degeneration of <italic>Gfi1<sup>-/-</sup></italic> HCs does not begin by E16.5. Presence of Pou4f3 in <italic>Gfi1<sup>-/-</sup></italic>HCs agreed with previous notion that Pou4f3 is epistatic to Gfi1. Collectively, analysis of both <italic>Gfi1</italic> mutant models supports that Gfi1 is dispensable for Rbm24 expression.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Forced expression of Rbm24 fails to rescue the OHC degeneration in <italic>Pou4f3</italic><sup>-/-</sup> mutants.</title>
<p><bold>(A)</bold> Generation of <italic>Rosa26-Loxp-stop-Loxp-Rbm24*3ξHA/+</italic> (<italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic>) mouse stain. The C-terminus of the ectopic Rbm24 was tagged with three HA tags. <bold>(B)</bold> One exampled tail PCR gel image that helped us to distinguish WT (+/+) and KI (<italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic>) mice. <bold>(C-F’’)</bold> Dual staining of HA (Rbm24) and hair cell marker Myo7a in mice with four different genotypes at P1: <italic>Pou4f3<sup>+/+</sup></italic> (C-C’’, n=3), <italic>Pou4f3<sup>-/-</sup></italic> (D-D’’, n=3) and <italic>Pou4f3<sup>+/+</sup></italic>; <italic>Atoh1<sup>Cre/+</sup></italic>; <italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic>(E-E’’, n=3) and <italic>Pou4f3<sup>-/-</sup></italic>; <italic>Atoh1<sup>Cre/+</sup></italic>; <italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic> (F-F’’, n=3). The ectopic HA (Rbm24) was not detected in <italic>Pou4f3<sup>+/+</sup></italic> (C) and <italic>Pou4f3<sup>-/-</sup></italic> (D), but was detected in both <italic>Pou4f3<sup>+/+</sup></italic>; <italic>Atoh1<sup>Cre/+</sup></italic>; <italic>Rosa26<sup>Rbm24/+</sup></italic>(E) and <italic>Pou4f3<sup>-/-</sup></italic>; <italic>Atoh1<sup>Cre/+</sup></italic>; <italic>Rosa26<sup>Rbm24/+</sup></italic>(F). The white arrows in (E-E’’) pointed to one Myo7a+ IHC that expressed the ectopic HA (Rbm24). The HCs seemed normal by P1, despite the ectopic Rbm24 expression was induced. The orange arrows in (E-E’’) labelled one SC that expressed HA (Rbm24) but not Myo7a. The white arrows in (F-F’’) should be one remaining Myo7a+ HC that expressed ectopic Rbm24. Overall, many of the <italic>Pou4f3<sup>-/-</sup></italic> HCs degenerated, albeit ectopic Rbm24 was induced. OHC: outer hair cell; IHC: inner hair cell; HC: hair cell. Scale bar: 20 μm (F’’).</p></caption>
<graphic xlink:href="546097v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2e">
<title>Pou4f3 and Gfi1 expressions are normal in <italic>Rbm24<sup>-/-</sup></italic> cochlear HCs</title>
<p>Given that Pou4f3 is upstream and positive regulator of <italic>Rbm24</italic>, we predicted that Pou4f3 expression should be unaffected in the <italic>Rbm24<sup>-/-</sup></italic> HCs. To determine whether the predication was correct or not, we established the <italic>Rbm24<sup>-</sup></italic><sup>/-</sup> mouse strain by injecting one <italic>Rbm24</italic> sgRNA (sgRNA-10) into one-cell stage zygotes derived from male <italic>Gfi1<sup>HA-Cre/+</sup></italic> mice (<xref rid="fig3" ref-type="fig">Figure 3A</xref>). We chose <italic>Gfi1<sup>HA-Cre/+</sup></italic> zygotes in order to simultaneously assess Gfi1 and Pou4f3 expression patterns in <italic>Rbm24<sup>-</sup></italic><sup>/-</sup> HCs. Relative to the control <italic>Gfi1<sup>HA-Cre/+</sup>; Rbm24<sup>+/+</sup></italic> (<xref rid="fig3" ref-type="fig">Figure 3B</xref>), premature emerge of the TAG stop codon appeared in the <italic>Gfi1<sup>HA-Cre/+</sup>; Rbm24<sup>-/-</sup></italic> (mosaic) mice (<xref rid="fig3" ref-type="fig">Figure 3C</xref>). Notably, Sanger sequencing of tail DNA showed that the Rbm24 mutation was mosaic, as mixed ‘T’ and ‘C’ peak existed (red arrow in <xref rid="fig3" ref-type="fig">Figure 3C</xref>).</p>
<p>The mosaic inactivation of Rbm24 was further confirmed by triple staining of Rbm24, HA and Pou4f3 (<xref rid="fig3" ref-type="fig">Figure 3D-E</xref>’’’). Relative to control <italic>Gfi1<sup>HA-Cre/+</sup>; Rbm24<sup>+/+</sup></italic> (n=3, <xref rid="fig3" ref-type="fig">Figure 3D-D</xref>’’’), Rbm24 expression disappeared in a fraction of cochlear HCs (orange arrows in <xref rid="fig3" ref-type="fig">Figure 3E-E</xref>’’’) but remained normal in other HCs (blue arrows in <xref rid="fig3" ref-type="fig">Figure 3E-E</xref>’’’) of the <italic>Gfi1<sup>HA-Cre/+</sup>; Rbm24<sup>-/-</sup></italic> (mosaic) mice (n=3) at E17. Notably, regardless of whether Rbm24 was inactivated or not in the cochlear HCs, both HA (Gfi1) and Pou4f3 expression patterns were intact. It supports that Pou4f3 is epistatic to Rbm24 and deletion of Rbm24 does not affect Pou4f3 expression. Moreover, our data suggests that Gfi1 and Rbm24 do not have genetic interactions. Gfi1 inactivation did not affect Rbm24 (<xref rid="fig2" ref-type="fig">Figure 2</xref> and <xref ref-type="fig" rid="figs5">Supplemental Figure 5</xref>), and vice versa (<xref rid="fig3" ref-type="fig">Figure 3E-E</xref>’’’).</p>
</sec>
<sec id="s2f">
<title>Three <italic>Rbm24</italic> enhancers can drive specific EGFP expression in cochlear HCs</title>
<p>After showing that Pou4f3, but not Gfi1, is indispensable in mediating <italic>Rbm24</italic> expression, we next determined the mechanism underlying how Pou4f3 controls <italic>Rbm24</italic> expression, in particular, the <italic>cis</italic>-regulation elements (CREs) of <italic>Rbm24</italic>. According to our previous Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq) of neonatal cochlear HCs <sup><xref ref-type="bibr" rid="c8">8</xref></sup>, four CREs of <italic>Rbm24</italic> were identified: one proximal promoter (arrow in <xref rid="fig4" ref-type="fig">Figure 4A</xref>) and three distal ones that were potential enhancers and defined as Eh1, Eh2 and Eh3, respectively (dotted square in <xref rid="fig4" ref-type="fig">Figure 4A</xref>). Eh1 and Eh2 were distributed upstream, whereas Eh3 was downstream of <italic>Rbm24</italic> coding region. Moreover, we reanalyzed the Pou4f3 Cut&amp;Run assay from one previous study <sup><xref ref-type="bibr" rid="c32">32</xref></sup>, and found that Pou4f3 binds to Eh1, Eh2 and Eh3, but not to the <italic>Rbm24</italic> promoter (<xref rid="fig4" ref-type="fig">Figure 4A</xref>).</p>
<p>Whether Eh1, Eh2 and Eh3 are bona-fide <italic>Rbm24</italic> enhancers remain to be determined. We reasoned that, if Eh1, Eh2 and Eh3 were <italic>Rbm24</italic> enhancers, either of them, together with the mini promoter of mouse heat shock protein 68 (Hsp68) <sup><xref ref-type="bibr" rid="c8">8</xref>, <xref ref-type="bibr" rid="c41">41</xref>–<xref ref-type="bibr" rid="c43">43</xref></sup>, would be sufficient to drive specific reporter expression in cochlear HCs. To address this question, we established three transgenic mouse strains: Eh1-EGFP+ (n=7, <xref rid="fig4" ref-type="fig">Figure 4B-C</xref>’’), Eh2-EGFP+ (n=6, <xref rid="fig4" ref-type="fig">Figure 4D-E</xref>’’) and Eh3-EGFP+ (n=4, <xref rid="fig4" ref-type="fig">Figure 4F-G</xref>’’). Briefly, in each strain the EGFP expression was driven by the mini promoter of Hsp68 and Eh1 (or Eh2 or Eh3). It is known that the mini promoter of <italic>Hsp68</italic> alone is not able to drive EGFP expression <sup><xref ref-type="bibr" rid="c44">44</xref></sup>. In contrast, strong EGFP expression was observed by whole mount analysis in all three transgenic lines (<xref rid="fig4" ref-type="fig">Figure 4B, D</xref> and <xref ref-type="fig" rid="figs4">F</xref>). Moreover, dual staining of EGFP and Myo7a in cryosectioned cochleae showed that EGFP was specifically expressed in IHCs and OHCs in all three strains at P1 (<xref rid="fig4" ref-type="fig">Figure 4C-C</xref>’’, E-E’’ and <xref ref-type="fig" rid="fig4">G-G</xref>’’). Collectively, our transgenic assay supports that Eh1, Eh2 and Eh3 are <italic>Rbm24</italic> enhancers. Moreover, Pou4f3 mediates the <italic>Rbm24</italic> expression primarily by binding to <italic>Rbm24</italic> enhancers.</p>
</sec>
<sec id="s2g">
<title>Forced Rbm24 expression fails to alleviate the degeneration of <italic>Pou4f3<sup>-/-</sup></italic>HCs</title>
<p>Whether ectopic Rbm24 expression can alleviate the degeneration of <italic>Pou4f3<sup>-/-</sup></italic> HCs remains unknown, albeit we showed that Rbm24 is certainly regulated by Pou4f3. Thus, we established a new conditional <italic>Rosa26</italic>-Loxp-stop-Loxp-Rbm24*3xHA/+ (<italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic> in short) mouse model (<xref rid="fig5" ref-type="fig">Figure 5A</xref> and <xref ref-type="fig" rid="fig5">B</xref>). To turn on ectopic Rbm24 in cochlear HCs, <italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic> was further crossed with the <italic>Atoh1<sup>Cre/+</sup></italic> that targets majority of cochlear HCs and a fraction of SCs <sup><xref ref-type="bibr" rid="c39">39</xref></sup>. Notably, in the <italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic>strain, Rbm24 was tagged with three HA fragments, which facilitated us to distinguish the endogenous and the ectopic Rbm24. In the control <italic>Pou4f3<sup>+/+</sup></italic> (<xref rid="fig5" ref-type="fig">Figure 5C-C</xref>’’) and the germ line stable <italic>Pou4f3<sup>-/-</sup></italic> (<xref rid="fig5" ref-type="fig">Figure 5D-D</xref>’’) mice, the Myo7a+ HCs did not express HA (Rbm24), however, almost of all Myo7a+ HCs expressed HA (Rbm24) in the <italic>Pou4f3<sup>+/+</sup></italic>; <italic>Atoh1<sup>Cre/+</sup></italic>; <italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic>mice at P1 (white arrows in <xref rid="fig5" ref-type="fig">Figure 5E-E</xref>’’). As expected, besides HCs, we captured a few SCs expressing HA (Rbm24) but not Myo7a (orange arrows in <xref rid="fig5" ref-type="fig">Figure 5E-E</xref>’’). Those cochlear HCs expressing HA (Rbm24) seemed normal, suggesting that they can tolerate extra Rbm24 expression by P1. Collectively, it supports that the <italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic>model was successfully generated and ectopic Rbm24 was induced in cochlear HCs in <italic>Pou4f3<sup>+/+</sup></italic>; <italic>Atoh1<sup>Cre/+</sup></italic>; <italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic>.</p>
<p>In contrast to our expectation, ectopic Rbm24 expression failed to mitigate the degeneration of <italic>Pou4f3<sup>-/-</sup></italic> HCs. Severe degeneration of HCs (both IHCs and OHCs) occurred in <italic>Pou4f3<sup>-/-</sup></italic>; <italic>Atoh1<sup>Cre/+</sup></italic>; <italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic>(<xref rid="fig5" ref-type="fig">Figure 5F-F</xref>’’), indistinguishable from the <italic>Pou4f3<sup>-/-</sup></italic>mice (<xref rid="fig5" ref-type="fig">Figure 5D-D</xref>’’), except that the remaining HCs expressed Rbm24 in the <italic>Pou4f3<sup>-/-</sup></italic>; <italic>Atoh1<sup>Cre/+</sup></italic>; <italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic> (arrows in <xref rid="fig5" ref-type="fig">Figure 5F-F</xref>’’). It suggests that restoration of Rbm24 alone is not sufficient to prevent <italic>Pou4f3<sup>-/-</sup></italic> cochlear HCs from undergoing degeneration.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<sec id="s3a">
<title>Molecular mechanisms underlying cochlear HC survival</title>
<p>Our sound receptor HCs are vulnerable to various genetic mutations, environmental ototoxic factors and ageing. The degeneration of HCs is one of the primary reasons accounting for human sensorineural hearing impairment <sup><xref ref-type="bibr" rid="c45">45</xref></sup>. Previous studies have revealed many genes whose mutations lead to HC degeneration starting at different ages. Severe HC developmental defect happens in <italic>Atoh1 <sup>-/-</sup></italic> mutants <sup><xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c46">46</xref></sup>. It is known that <italic>Atoh1<sup>-/-</sup></italic> cochlear sensory cells undergo apoptosis. Whether the absence of HCs in <italic>Atoh1<sup>-/-</sup></italic> mice is due to that HCs are never produced, or immediately die after initial emergence remains unclear, partly due to the difficulty of unambiguously defining the nascent HCs by molecular markers.</p>
<p>Differently from <italic>Atoh1<sup>-/-</sup></italic> mutants, in both <italic>Pou4f3<sup>-/-</sup></italic>and <italic>Gfi1<sup>-/-</sup></italic> mice <sup><xref ref-type="bibr" rid="c31">31</xref>, <xref ref-type="bibr" rid="c33">33</xref>, <xref ref-type="bibr" rid="c34">34</xref></sup>, the initial cochlear HC development is normal but become defective at perinatal ages, consistent with the notion that Pou4f3 and Gfi1 are not required in HC fate specification but needed in subsequent differentiation and survival. It is known that caspase 3 is active during the hair cell death in the <italic>Pou4f3<sup>-/-</sup></italic> mutants, and the anti-apoptotic factor z-VAD-fmk has a protective effect on the <italic>Pou4f3<sup>-/-</sup></italic>HCs between 14.5 and E16.5 <sup><xref ref-type="bibr" rid="c47">47</xref></sup>. Moreover, we noticed that the overall HC degeneration in <italic>Gfi1<sup>-/-</sup></italic> was milder than in <italic>Pou4f3<sup>-/-</sup></italic> mice at P1, because only OHC degeneration happened in the <italic>Gfi1<sup>-/-</sup></italic>, but both IHC and OHC were degenerated in <italic>Pou4f3<sup>-/-</sup></italic> mice (<xref rid="figs2" ref-type="fig">Supplemental Figures 2</xref> and <xref rid="fig5" ref-type="fig">5</xref>).</p>
<p>It is known that <italic>Gfi1</italic> is the target of Pou4f3 <sup><xref ref-type="bibr" rid="c34">34</xref></sup>. Whether forced Gfi1 expression can alleviate the degeneration of <italic>Pou4f3<sup>-/-</sup></italic> HCs remains unknown, too. Likewise, Pou4f3 is one of the target genes regulated by Atoh1 <sup><xref ref-type="bibr" rid="c32">32</xref></sup>, however, whether forced expression of either Pou4f3 or Gfi1, or both Pou4f3 and Gfi1, is able to mitigate the developmental defects of <italic>Atoh1<sup>-/-</sup></italic> HCs remains to be determined. Future studies are warranted to resolve those remaining questions before further deeply understanding the mechanisms underlying how to keep cochlear HCs to survive.</p>
</sec>
<sec id="s3b">
<title>Roles of Rbm24 and how Rbm24 is regulated during cochlear HC development</title>
<p>Shortly after cochlear HCs emerge, Rbm24 is expressed and permanently maintained, evidenced by transcriptomic analyses and antibody staining <sup><xref ref-type="bibr" rid="c23">23</xref>, <xref ref-type="bibr" rid="c35">35</xref>, 48–<xref ref-type="bibr" rid="c50">50</xref></sup>. Rbm24 is not necessary in early phase of cochlear HC development, because <italic>Rbm24<sup>-/-</sup></italic>HC development is normal by P1, however, Rbm24 is required for OHC to survive after birth <sup><xref ref-type="bibr" rid="c36">36</xref></sup>. <italic>Rbm24<sup>-/-</sup></italic> OHCs, but not IHCs, are degenerated by P19 <sup><xref ref-type="bibr" rid="c36">36</xref></sup>. Rbm24 is also involved in mRNA stability and pre-mRNA alternative splicing of genes including <italic>Cdh23</italic> and <italic>Pcdh15</italic> that are crucial for HC stereocilia development <sup><xref ref-type="bibr" rid="c51">51</xref>–<xref ref-type="bibr" rid="c53">53</xref></sup>. Nonetheless, the single-cell transcriptomic analysis of <italic>Rbm24<sup>-/-</sup></italic> IHCs or OHCs is not yet available and the detailed molecular mechanism underlying <italic>Rbm24<sup>-/-</sup></italic>HC degeneration remains to be clarified in future studies.</p>
<p>What are the <italic>trans</italic>-acting factors that are involved in regulating <italic>Rbm24</italic> expression? First, our current study provided strong genetic evidence to support that Pou4f3 is needed in turning on <italic>Rbm24</italic>. In the absence of Pou4f3, Rbm24 expression cannot be triggered. The normal expression of Pou4f3 in <italic>Rbm24<sup>-/-</sup></italic> HCs further confirmed that <italic>Pou4f3</italic> is epistatic to <italic>Rbm24</italic> and that Rbm24 is dispensable for <italic>Pou4f3</italic> expression. Besides Pou4f3, the engagement of Atoh1 in <italic>Rbm24</italic> regulation is supported by two lines of evidence: one is that <italic>Rbm24</italic> expression disappears in the <italic>Atoh1<sup>-/-</sup></italic> cochlear HCs <sup><xref ref-type="bibr" rid="c54">54</xref></sup>; the second is that <italic>Rbm24</italic> belongs to the Atoh1 binding targets revealed by Atoh1 Cut&amp;Run assay <sup><xref ref-type="bibr" rid="c8">8</xref>, <xref ref-type="bibr" rid="c32">32</xref></sup>. Notably, Atoh1 binds both <italic>Rbm24</italic> promoter and its three enhancers Eh1, Eh2 and Eh3 <sup><xref ref-type="bibr" rid="c8">8</xref>, <xref ref-type="bibr" rid="c32">32</xref></sup>, which differs with Pou4f3 which only binds <italic>Rbm24</italic> enhancers (<xref rid="fig4" ref-type="fig">Figure 4</xref>). Thus, it is likely that Pou4f3 and Atoh1 cooperate to regulate <italic>Rbm24</italic>, and either <italic>Pou4f3</italic> or <italic>Atoh1</italic> mutation leads to repression of Rbm24 expression. Whether <italic>Rbm24</italic> expression in adult HCs needs Pou4f3 remains to be determined by future conditional <italic>Pou4f3</italic> loss-of-function studies.</p>
</sec>
<sec id="s3c">
<title>Gfi1 and Rbm24 expression are independent to each other</title>
<p>We initially hypothesized that Pou4f3 mediated <italic>Rbm24</italic> expression through Gfi1. However, this hypothesis is not supported by the observation that Rbm24 expression is normal in the <italic>Gfi1<sup>-/-</sup></italic> HCs (<xref rid="fig2" ref-type="fig">Figure 2</xref> and <xref rid="figs5" ref-type="fig">Supplemental Figure 5</xref>). Moreover, in the absence of Rbm24, Gfi1 expression is not altered in cochlear HCs, either. Thus, Rbm24 and Gfi1 expressions seem independent to each other. It might be due to the functional difference between Pou4f3 and Gfi1 during cochlear HC development. Both Pou4f3 and Gfi1 are needed in promoting expression of genes involved in HC differentiation <sup><xref ref-type="bibr" rid="c28">28</xref>, <xref ref-type="bibr" rid="c30">30</xref>, <xref ref-type="bibr" rid="c34">34</xref>, <xref ref-type="bibr" rid="c40">40</xref></sup>, however, Gfi1, but not Pou4f3, also represses the preceding neural genes expressed in nascent HCs <sup><xref ref-type="bibr" rid="c40">40</xref></sup>.</p>
<p>Furthermore, we have another observation relevant to Gfi1 isoforms that is worthy of discussion. Our previous report shows that one efficient sgRNA is enough to induce homozygous gene inactivation by CRISPR-stop <sup><xref ref-type="bibr" rid="c36">36</xref></sup>. Notably, we used 4 different <italic>Gfi1</italic> sgRNAs that are distributed in different exons (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). We indeed successfully established one <italic>Gfi1</italic> mutant by using the sgRNA-5 alone which in principle would effectively pre-stop the Gfi1 translation in exon 1 coding SNAG repressor domain. This <italic>Gfi1</italic> mutant (sgRNA-5 alone) was able to yield the HC degeneration phenotype, but the HA (Gfi1) was still detectable in HCs. It is consistent with the notion that <italic>Gfi1</italic> mutant lacing the SNAG domain is equivalent to <italic>Gfi1</italic>-null model <sup><xref ref-type="bibr" rid="c55">55</xref></sup>. Thus, it is likely that Gfi1 has multiple unknown isoforms, many of which might be recognized by the HA tag antibody because HA is tagged in the last exon 6. When 4 <italic>Gfi1</italic> sgRNAs were combined, we were able to both reproduce the HC degeneration phenotype and completely block the HA (Gfi1) expression.</p>
</sec>
<sec id="s3d">
<title>Why does ectopic Rbm24 fail to alleviate the degeneration of <italic>Pou4f3<sup>-/-</sup></italic> HCs?</title>
<p>After confirming the epistatic genetic interaction between Pou4f3 and Rbm24, we predicted that ectopic Rbm24 expression should be able to, at least partly, alleviate the degeneration of <italic>Pou4f3<sup>-/-</sup></italic> HCs, similar to the case between Insm1 and Ikzf2 in cochlear OHCs in our recent study <sup><xref ref-type="bibr" rid="c21">21</xref></sup>. However, the actual observation is that Rbm24 failed to rescue the HC degeneration in the <italic>Pou4f3<sup>-/-</sup></italic>mice. There are two possible interpretations: 1) Despite it is regulated by Pou4f3, Rbm24 is not directly involved in the pathway regulating HC survival. Indeed, the cell death in <italic>Rbm24<sup>-/-</sup></italic> HCs happens later than in <italic>Pou4f3<sup>-/-</sup></italic> HCs; 2) Although <italic>Rbm24</italic> is a key Pou4f3 downstream target, its forced expression alone cannot compensate loss of Pou4f3 or other known Pou4f3 targets such as orphan thyroid nuclear receptor <italic>Nr2f2</italic> and <italic>Caprin-1</italic> <sup><xref ref-type="bibr" rid="c56">56</xref>, <xref ref-type="bibr" rid="c57">57</xref></sup>. <italic>Caprin-1</italic> is recruited to stress granules in cochlear HCs exposed to ototoxic trauma <sup><xref ref-type="bibr" rid="c57">57</xref></sup>.</p>
</sec>
<sec id="s3e">
<title>The potential application of the three <italic>Rbm24</italic> enhancers in cochlear HC gene therapy</title>
<p>Gene therapy is a promising strategy to restore the hearing capacity in human inheriting gene mutations <sup><xref ref-type="bibr" rid="c45">45</xref></sup>. A few examples have been reported, including <italic>Otoferlin</italic> and <italic>vGlut3</italic> gene replacement <sup><xref ref-type="bibr" rid="c58">58</xref>–<xref ref-type="bibr" rid="c61">61</xref></sup>. Currently, the therapeutic cDNAs were primarily delivered into HCs with an adeno-associated virus (AAV) vector. Despite many AAVs are reported <sup><xref ref-type="bibr" rid="c62">62</xref>, <xref ref-type="bibr" rid="c63">63</xref></sup>, their transfecting cochlear cells is non-selective and HC specific AAV is not available yet. One solution is that, instead of the CAG/CMV ubiquitous promoter widely used in current AAVs <sup><xref ref-type="bibr" rid="c64">64</xref>, <xref ref-type="bibr" rid="c65">65</xref></sup>, either of the three <italic>Rbm24</italic> enhancers together with <italic>Hsp68</italic> mini promoter (in brief <italic>Rbm24-Hsp68</italic>) should be able to produce an AAV that would specifically transfect HCs. Moreover, <italic>Rbm24</italic> is permanently expressed in cochlear HCs. Given the <italic>Rbm24-Hsp68</italic> AAV works as expected, it would be a powerful tool for future HC specific gene therapy at all postnatal ages, with potential applications in treating clinical human deafness.</p>
</sec>
</sec>
<sec id="s4">
<title>Methods and materials</title>
<sec id="s4a">
<title>Mice</title>
<p>The <italic>Atoh1<sup>Cre/+</sup></italic> model was kindly provided by Dr Lin Gan (Augusta University, USA)<sup><xref ref-type="bibr" rid="c39">39</xref></sup>. The <italic>Rosa26-loxp-stop-loxp-tdTomato (</italic>Ai9<italic>)/+</italic> strain (Jax#: 007905) was from the Jackson Laboratory. All mice were bred and raised in a SPF-level animal room and all animal procedures were performed according to the guidelines (NA-032-2022) of the IACUC of the Institute of Neuroscience (ION), Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences.</p>
</sec>
<sec id="s4b">
<title>One-step generation of homozygous <italic>Pou4f3</italic> or <italic>Gfi1</italic> or <italic>Rbm24</italic> mutants by CRISPR-stop</title>
<p>The detailed protocol of how to use CRISPR-stop to generate homozygous gene mutants is described in our previous report <sup><xref ref-type="bibr" rid="c36">36</xref>, <xref ref-type="bibr" rid="c37">37</xref></sup>. Briefly, efficient pre-tested sgRNAs (Table S1) and hA3ABE3 were co-injected into one-cell stage mouse zygotes that were subsequently transplanted into pseudopregnant female mice giving birth to the founder 0 (F0) mice. With Sanger sequencing of tail PCR, the F0 mice with homozygous mutation (pre-emergence of protein translation stop codon) were identified and immediately ready for analysis.</p>
</sec>
<sec id="s4c">
<title>Generating <italic>Pou4f3</italic> or <italic>Gfi1</italic>-null mutants with large DNA fragment deletion by CRISPR/Cas9</title>
<p>To construct germ line stable null mutants of either <italic>Pou4f3</italic> or <italic>Gfi1</italic>, <italic>Cas9</italic> mRNA, two efficient pre-tested sgRNAs respectively located at the proximal and distal end of the targeted gene, together with a single strand DNA donor (120 bp) (Table S3), were co-injected into the one-cell stage wild type zygotes. Notably, the left half (60 bp) of the single strand DNA donor was homologous to the 5’ end, and the right half (60 bp) was to the 3’end of the targeted gene. The post-injected zygotes were transplanted into pseudopregnant females that would give birth to the F0 mice subjected to tail PCR screening (primers were listed in Table S2). The F0 mice harboring the designed large DNA deletion between the two sgRNAs were identified and further bred with wild type mice to establish the germ-line stable mutants (F1 or afterward).</p>
</sec>
<sec id="s4d">
<title>Construction of the <italic>Gfi1*3×HA-P2A-Cre</italic> knockin mouse strain</title>
<p>The sgRNA against <italic>Gfi1</italic> (5ʹ-ATGGACTCAAATGAGTACCC-3ʹ), <italic>Cas9</italic> mRNA and the targeting vector (<xref ref-type="fig" rid="figs3">Supplemental Figure 3B</xref>) were co-injected into the one-cell stage wild type mouse zygotes. The targeting vector contained three portions, 5’ homologous arm (800 bp), 3’ homologous arm (800 bp) and the part in the middle of 5’ and 3’ arms that contained three HA fragments followed by 2A-Cre. The F0 mice with the potential gene targeting (<xref rid="figs3" ref-type="fig">Supplemental Figure 3C</xref>) were screened by tail PCR, followed by crossing with wild type mice to produce F1 mice. Those F1 mice were confirmed by tail PCR again, and further subjected to Southern blot. The detailed protocol of Southern blot is described in our previous report <sup><xref ref-type="bibr" rid="c66">66</xref></sup>. Tail DNA PCR was used for routine genotyping and primers used to distinguish between KI (<italic>Gfi1<sup>HA-Cre/+</sup></italic>) and WT alleles were F4, R5 and R6 (Table S2).</p>
</sec>
<sec id="s4e">
<title>Construction of Eh1-EGFP+, Eh2-EGFP+ and Eh3-EGFP+ transgenic reporter lines</title>
<p>All three transgenic reporter mouse lines, Eh1-EGFP+, Eh2-EGFP+ and Eh3-EGFP+ were produced by the same experimental procedures. The core DNA sequences of each enhancer (Eh1 or Eh2 or Eh3 in <xref rid="fig4" ref-type="fig">Figure 4A</xref>), mRNA of PiggyBac transposase, and the PiggyBac vector (<xref rid="fig4" ref-type="fig">Figure 4B, D</xref> and <xref ref-type="fig" rid="fig4">F</xref>) were co-injected into the one-cell stage of wild type mouse zygotes. The PiggyBac vector contained Eh1/Eh2/Eh3 core DNA sequences (Table S3), mini promoter of mouse heat shock protein 68 (Hsp68) and the EGFP coding sequence. The PiggyBac vector was randomly integrated into mouse genome by the transposase. The F0 mice containing the PiggyBac vector were screened by tail PCR and further bred with wild type mice to produce germ line stable F1 transgenic reporter strains. The samples analyzed in <xref rid="fig4" ref-type="fig">Figure 4B-G</xref>’’ were from F1 or afterwards. Primers used for genotyping transgenic reporter strain were F8, F9 and F10 and a common primer R11 and primer sequences were listed in Table S2.</p>
</sec>
<sec id="s4f">
<title>Generation of Rosa26<sup>CAG-lsl-Rbm</sup><sup><xref ref-type="bibr" rid="c24">24</xref></sup><sup>*3×HA/+</sup> mouse models</title>
<p>The <italic>Rosa26<sup>CAG-lsl-Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>*3×HA/+</sup></italic> (<italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic>) knockin mouse strain was constructed by homologous recombination mediated by CRISPR/Cas9. The pre-tested <italic>Rosa26</italic> sgRNA (5ʹ-<italic>ACTCCAGTCTTTCTAGAAGA</italic>-3ʹ), targeting vector (<xref rid="fig5" ref-type="fig">Figure 5A</xref>), together with the mRNA of <italic>Cas9</italic> were co-injected into the one-cell stage wild type mouse zygotes. Similarly, F0 mice with potentially correct gene targeting were screened by tail PCR and further bred with wild type mice to establish germ line stable F1 mice. The primers used to distinguish wild type and the KI (<italic>Rosa26<sup>Rbm</sup></italic><sup><xref ref-type="bibr" rid="c24">24</xref></sup><italic><sup>/+</sup></italic>) alleles were F12, R13 and R14 (Table S2).</p>
</sec>
<sec id="s4g">
<title>Sample processing and immunofluorescence assay</title>
<p>Inner ears were dissected and fixed in 4% paraformaldehyde (PFA) in PBS (E607016-0500, Sangon Biotech) at 4℃ overnight. For cochlear cryosections, inner ears were dehydrated in 30% sucrose (V900116, Sigma) at 4℃ before embedding into the optimal cutting temperature (OCT) compound (4583, SAKURA) and slices were cut with 14 μm thickness. The detailed protocol of immunofluorescent staining is described in our previous report <sup><xref ref-type="bibr" rid="c67">67</xref></sup>. The following primary antibodies were used: anti-Rbm24 (rabbit, 1:500, 18178-1-AP, Proteintech); anti-Pou4f3 (mouse, 1:500, sc-81980, Santa Cruz); anti-Pou4f3 (rabbit, 1:500, NBP1-88349, Novus Biologicals); anti-HA (rat, 1:500, 11867423001, Roche); anti-Myo7a (rabbit, 1:500, 25-6790, Proteus Biosciences); anti-Myo7a (mouse, 1:500, MYO7A 138-1, Developmental Studies Hybridoma Bank); anti-Ctip2 (Bcl11b) (rat, 1:500, ab18465, Abcam); anti-Insm1 (guinea pig, 1:6000, a kind gift from Dr. Carmen Birchmeier from Max Delbrueck Center for Molecular Medicine, Germany); anti-GFP (chicken, 1:500, ab13970, Abcam). Different corresponding Alexa Fluor-conjugated secondary antibodies were used for detecting the primary antibodies above. Hoechst 33342 (1:1000, H3570, Thermo Fisher Scientific) was used for nuclear DNA staining.</p>
<p>Lastly, either whole-mount or cryosection samples were mounted with Prolong Gold antifade medium (P36930, Thermo Fisher Scientific) at room temperature for 12 h. Samples were scanned by the Nikon C2 or Nikon NiE-A1 Plus confocal microscope. ImageJ software was used to process the confocal images.</p>
</sec>
<sec id="s4h">
<title>Cell quantification and statistical analysis</title>
<p>Before immunofluorescent staining, each cochlear sample was grossly separated into three portions but with different length. Each portion of the same cochlea was initially scanned with confocal microscope but at a low magnification (10◊lens). After calculating the total length of each cochlea, it was precisely divided into basal, middle and apical turn with equal length. Then, for cell counting in the experiments (<xref ref-type="fig" rid="figs2">Supplemental Figure 2D</xref>), in each turn ∼200μm length of the sensory epithelium was scanned with confocal microscope but at a high magnification (60◊lens) by which the number of HCs was counted. In the <italic>Pou4f3<sup>-/-</sup></italic> cochleae, the percentage of the surviving HCs was calculated by normalizing the number of the remaining HCs to the counterparts in the wild type mice. All cell numbers were presented as means ± SEM. For statistical analyses, we used GraphPad Prism 6.0 software and performed Student’s <italic>t</italic> tests with Bonferroni correction.</p>
</sec>
</sec>
<sec id="d1e2369" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="d1e2456">
<label>Supplemental Table 1</label>
<media xlink:href="supplements/546097_file02.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2463">
<label>Supplemental Table 2</label>
<media xlink:href="supplements/546097_file03.xlsx"/>
</supplementary-material>
<supplementary-material id="d1e2470">
<label>Supplemental Table 3</label>
<media xlink:href="supplements/546097_file04.xlsx"/>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Wu</surname>, <given-names>D.K.</given-names></string-name>, and <string-name><surname>Kelley</surname>, <given-names>M.W</given-names></string-name>. (<year>2012</year>). <article-title>Molecular mechanisms of inner ear development</article-title>. <source>Cold Spring Harb Perspect Biol</source> <volume>4</volume>, <fpage>a008409</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a008409</pub-id>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Qiu</surname>, <given-names>X.</given-names></string-name>, and <string-name><surname>Muller</surname>, <given-names>U</given-names></string-name>. (<year>2022</year>). <article-title>Sensing sound: Cellular specializations and molecular force sensors</article-title>. <source>Neuron</source> <volume>110</volume>, <fpage>3667</fpage>–<lpage>3687</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2022.09.018</pub-id>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Groves</surname>, <given-names>A.K.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>K.D.</given-names></string-name>, and <string-name><surname>Fekete</surname>, <given-names>D.M</given-names></string-name>. (<year>2013</year>). <article-title>The genetics of hair cell development and regeneration</article-title>. <source>Annu Rev Neurosci</source> <volume>36</volume>, <fpage>361</fpage>–<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-neuro-062012-170309</pub-id>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Fan</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Liu</surname>, <given-names>Z</given-names></string-name>. (<year>2022</year>). <article-title>Fate-mapping analysis of cochlear cells expressing Atoh1 mRNA via a new Atoh1(3*HA-P2A-Cre) knockin mouse strain</article-title>. <source>Dev Dyn</source>, DOI: <pub-id pub-id-type="doi">10.1002/dvdy.1453.10.1002/dvdy.453</pub-id>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Driver</surname>, <given-names>E.C.</given-names></string-name>, <string-name><surname>Sillers</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Coate</surname>, <given-names>T.M.</given-names></string-name>, <string-name><surname>Rose</surname>, <given-names>M.F.</given-names></string-name>, and <string-name><surname>Kelley</surname>, <given-names>M.W</given-names></string-name>. (<year>2013</year>). <article-title>The Atoh1-lineage gives rise to hair cells and supporting cells within the mammalian cochlea</article-title>. <source>Dev Biol</source> <volume>376</volume>, <fpage>86</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2013.01.005</pub-id>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Matei</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Pauley</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kaing</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Rowitch</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Beisel</surname>, <given-names>K.W.</given-names></string-name>, <string-name><surname>Morris</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Feng</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Fritzsch</surname>, <given-names>B</given-names></string-name>. (<year>2005</year>). <article-title>Smaller inner ear sensory epithelia in Neurog 1 null mice are related to earlier hair cell cycle exit</article-title>. <source>Dev Dyn</source> <volume>234</volume>, <fpage>633</fpage>–<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.20551</pub-id>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Bermingham</surname>, <given-names>N.A.</given-names></string-name>, <string-name><surname>Hassan</surname>, <given-names>B.A.</given-names></string-name>, <string-name><surname>Price</surname>, <given-names>S.D.</given-names></string-name>, <string-name><surname>Vollrath</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>Ben-Arie</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Eatock</surname>, <given-names>R.A.</given-names></string-name>, <string-name><surname>Bellen</surname>, <given-names>H.J.</given-names></string-name>, <string-name><surname>Lysakowski</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Zoghbi</surname>, <given-names>H.Y</given-names></string-name>. (<year>1999</year>). <article-title>Math1: an essential gene for the generation of inner ear hair cells</article-title>. <source>Science</source> <volume>284</volume>, <fpage>1837</fpage>–<lpage>1841</lpage>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Luo</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Du</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Shu</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>F.</given-names></string-name>, and <string-name><surname>Liu</surname>, <given-names>Z</given-names></string-name>. (<year>2022</year>). <article-title>Three distinct Atoh1 enhancers cooperate for sound receptor hair cell development</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>119</volume>, <issue>e2119850119</issue>. <pub-id pub-id-type="doi">10.1073/pnas.2119850119</pub-id>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Zheng</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>D.Z.</given-names></string-name>, <string-name><surname>Long</surname>, <given-names>K.B.</given-names></string-name>, <string-name><surname>Madison</surname>, <given-names>L.D.</given-names></string-name>, and <string-name><surname>Dallos</surname>, <given-names>P</given-names></string-name>. (<year>2000</year>). <article-title>Prestin is the motor protein of cochlear outer hair cells</article-title>. <source>Nature</source> <volume>405</volume>, <fpage>149</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1038/35012009</pub-id>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Liberman</surname>, <given-names>M.C.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>D.Z.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Jia</surname>, <given-names>S.</given-names></string-name>, and <string-name><surname>Zuo</surname>, <given-names>J</given-names></string-name>. (<year>2002</year>). <article-title>Prestin is required for electromotility of the outer hair cell and for the cochlear amplifier</article-title>. <source>Nature</source> <volume>419</volume>, <fpage>300</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1038/nature01059</pub-id>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Ruel</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Emery</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Nouvian</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Bersot</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Amilhon</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Van Rybroek</surname>, <given-names>J.M.</given-names></string-name>, <string-name><surname>Rebillard</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Lenoir</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Eybalin</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Delprat</surname>, <given-names>B.</given-names></string-name>, <etal>et al.</etal> (<year>2008</year>). <article-title>Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice</article-title>. <source>Am J Hum Genet</source> <volume>83</volume>, <fpage>278</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2008.07.008</pub-id>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Seal</surname>, <given-names>R.P.</given-names></string-name>, <string-name><surname>Akil</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Yi</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Weber</surname>, <given-names>C.M.</given-names></string-name>, <string-name><surname>Grant</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Yoo</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Clause</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kandler</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Noebels</surname>, <given-names>J.L.</given-names></string-name>, <string-name><surname>Glowatzki</surname>, <given-names>E.</given-names></string-name>, <etal>et al.</etal> (<year>2008</year>). <article-title>Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3</article-title>. <source>Neuron</source> <volume>57</volume>, <fpage>263</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.11.032</pub-id>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Roux</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Safieddine</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Nouvian</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Grati</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Simmler</surname>, <given-names>M.C.</given-names></string-name>, <string-name><surname>Bahloul</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Perfettini</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Le Gall</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Rostaing</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Hamard</surname>, <given-names>G.</given-names></string-name>, <etal>et al.</etal> (<year>2006</year>). <article-title>Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse</article-title>. <source>Cell</source> <volume>127</volume>, <fpage>277</fpage>–<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.08.040</pub-id>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Pan</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>Z.</given-names></string-name>, and <string-name><surname>Xiang</surname>, <given-names>M</given-names></string-name>. (<year>2023</year>). <article-title>Fgf8(P2A-3xGFP/+): A New Genetic Mouse Model for Specifically Labeling and Sorting Cochlear Inner Hair Cells</article-title>. <source>Neurosci Bull</source>. <pub-id pub-id-type="doi">10.1007/s12264-023-01069-y</pub-id>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Jacques</surname>, <given-names>B.E.</given-names></string-name>, <string-name><surname>Montcouquiol</surname>, <given-names>M.E.</given-names></string-name>, <string-name><surname>Layman</surname>, <given-names>E.M.</given-names></string-name>, <string-name><surname>Lewandoski</surname>, <given-names>M.</given-names></string-name>, and <string-name><surname>Kelley</surname>, <given-names>M.W</given-names></string-name>. (<year>2007</year>). <article-title>Fgf8 induces pillar cell fate and regulates cellular patterning in the mammalian cochlea</article-title>. <source>Development</source> <volume>134</volume>, <fpage>3021</fpage>–<lpage>3029</lpage>. <pub-id pub-id-type="doi">10.1242/dev.02874</pub-id>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Petitpre</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Sharma</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Tokarska</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Fontanet</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Helmbacher</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Yackle</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Silberberg</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Hadjab</surname>, <given-names>S.</given-names></string-name>, and <string-name><surname>Lallemend</surname>, <given-names>F</given-names></string-name>. (<year>2018</year>). <article-title>Neuronal heterogeneity and stereotyped connectivity in the auditory afferent system</article-title>. <source>Nat Commun</source> <volume>9</volume>, <issue>3691</issue>. <pub-id pub-id-type="doi">10.1038/s41467-018-06033-3</pub-id>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Shrestha</surname>, <given-names>B.R.</given-names></string-name>, <string-name><surname>Chia</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Kujawa</surname>, <given-names>S.G.</given-names></string-name>, <string-name><surname>Liberman</surname>, <given-names>M.C.</given-names></string-name>, and <string-name><surname>Goodrich</surname>, <given-names>L.V</given-names></string-name>. (<year>2018</year>). <article-title>Sensory Neuron Diversity in the Inner Ear Is Shaped by Activity</article-title>. <source>Cell</source> <volume>174</volume>, <fpage>1229</fpage>–<lpage>1246</lpage> e1217. <pub-id pub-id-type="doi">10.1016/j.cell.2018.07.007</pub-id>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Sun</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Babola</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Pregernig</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>So</surname>, <given-names>K.S.</given-names></string-name>, <string-name><surname>Nguyen</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Su</surname>, <given-names>S.M.</given-names></string-name>, <string-name><surname>Palermo</surname>, <given-names>A.T.</given-names></string-name>, <string-name><surname>Bergles</surname>, <given-names>D.E.</given-names></string-name>, <string-name><surname>Burns</surname>, <given-names>J.C.</given-names></string-name>, and <string-name><surname>Muller</surname>, <given-names>U</given-names></string-name>. (<year>2018</year>). <article-title>Hair Cell Mechanotransduction Regulates Spontaneous Activity and Spiral Ganglion Subtype Specification in the Auditory System</article-title>. <source>Cell</source> <volume>174</volume>, <fpage>1247</fpage>–<lpage>1263</lpage> e1215. <pub-id pub-id-type="doi">10.1016/j.cell.2018.07.008</pub-id>.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Ren</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Bi</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Gu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, and <string-name><surname>Liu</surname>, <given-names>Z</given-names></string-name>. (<year>2023</year>). <article-title>Lypd1-DTR/+: A New Mouse Model for Specifically Damaging the Type Ic Spiral Ganglion Neurons of the Cochlea</article-title>. <source>Neurosci Bull</source>. <pub-id pub-id-type="doi">10.1007/s12264-023-01071-4</pub-id>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Wiwatpanit</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Lorenzen</surname>, <given-names>S.M.</given-names></string-name>, <string-name><surname>Cantu</surname>, <given-names>J.A.</given-names></string-name>, <string-name><surname>Foo</surname>, <given-names>C.Z.</given-names></string-name>, <string-name><surname>Hogan</surname>, <given-names>A.K.</given-names></string-name>, <string-name><surname>Marquez</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Clancy</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Schipma</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Cheatham</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>Duggan</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Garcia-Anoveros</surname>, <given-names>J</given-names></string-name>. (<year>2018</year>). <article-title>Trans-differentiation of outer hair cells into inner hair cells in the absence of INSM1</article-title>. <source>Nature</source> <volume>563</volume>, <fpage>691</fpage>–<lpage>695</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0570-8</pub-id>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Jia</surname>, <given-names>S.</given-names></string-name>, and <string-name><surname>Liu</surname>, <given-names>Z</given-names></string-name>. (<year>2023</year>). <article-title>Epistatic genetic interactions between Insm1 and Ikzf2 during cochlear outer hair cell development</article-title>. <source>Cell Rep</source> <volume>42</volume>, <issue>112504</issue>. <pub-id pub-id-type="doi">10.1016/j.celrep.2023.112504</pub-id>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Chessum</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Matern</surname>, <given-names>M.S.</given-names></string-name>, <string-name><surname>Kelly</surname>, <given-names>M.C.</given-names></string-name>, <string-name><surname>Johnson</surname>, <given-names>S.L.</given-names></string-name>, <string-name><surname>Ogawa</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Milon</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>McMurray</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Driver</surname>, <given-names>E.C.</given-names></string-name>, <string-name><surname>Parker</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>Y.</given-names></string-name>, <etal>et al.</etal> (<year>2018</year>). <article-title>Helios is a key transcriptional regulator of outer hair cell maturation</article-title>. <source>Nature</source> <volume>563</volume>, <fpage>696</fpage>–<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-018-0728-4</pub-id>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Bi</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Ren</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zhu</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>Y.</given-names></string-name>, and <string-name><surname>Liu</surname>, <given-names>Z</given-names></string-name>. (<year>2022</year>). <article-title>Development and transdifferentiation into inner hair cells require Tbx2</article-title>. <source>Natl Sci Rev</source> <volume>9</volume>, nwac156. <pub-id pub-id-type="doi">10.1093/nsr/nwac156</pub-id>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Garcia-Anoveros</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Clancy</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Foo</surname>, <given-names>C.Z.</given-names></string-name>, <string-name><surname>Garcia-Gomez</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Homma</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Cheatham</surname>, <given-names>M.A.</given-names></string-name>, and <string-name><surname>Duggan</surname>, <given-names>A</given-names></string-name>. (<year>2022</year>). <article-title>Tbx2 is a master regulator of inner versus outer hair cell differentiation</article-title>. <source>Nature</source> <volume>605</volume>, <fpage>298</fpage>–<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-022-04668-3</pub-id>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Kaiser</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ludtke</surname>, <given-names>T.H.</given-names></string-name>, <string-name><surname>Deuper</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Rudat</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Christoffels</surname>, <given-names>V.M.</given-names></string-name>, <string-name><surname>Kispert</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Trowe</surname>, <given-names>M.O</given-names></string-name>. (<year>2022</year>). <article-title>TBX2 specifies and maintains inner hair and supporting cell fate in the Organ of Corti</article-title>. <source>Nat Commun</source> <volume>13</volume>, <fpage>7628</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-022-35214-4</pub-id>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Vahava</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Morell</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lynch</surname>, <given-names>E.D.</given-names></string-name>, <string-name><surname>Weiss</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kagan</surname>, <given-names>M.E.</given-names></string-name>, <string-name><surname>Ahituv</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Morrow</surname>, <given-names>J.E.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>M.K.</given-names></string-name>, <string-name><surname>Skvorak</surname>, <given-names>A.B.</given-names></string-name>, <string-name><surname>Morton</surname>, <given-names>C.C.</given-names></string-name>, <etal>et al.</etal> (<year>1998</year>). <article-title>Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans</article-title>. <source>Science</source> <volume>279</volume>, <fpage>1950</fpage>–<lpage>1954</lpage>. <pub-id pub-id-type="doi">10.1126/science.279.5358.1950</pub-id>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Masuda</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Dulon</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Pak</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Mullen</surname>, <given-names>L.M.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Erkman</surname>, <given-names>L.</given-names></string-name>, and <string-name><surname>Ryan</surname>, <given-names>A.F</given-names></string-name>. (<year>2011</year>). <article-title>Regulation of POU4F3 gene expression in hair cells by 5’ DNA in mice</article-title>. <source>Neuroscience</source> <volume>197</volume>, <fpage>48</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.09.033</pub-id>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Xiang</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gan</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>Z.Y.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>O’Malley</surname>, <given-names>B.W.</given-names>, <suffix>Jr.</suffix></string-name>, <string-name><surname>Klein</surname>, <given-names>W.</given-names></string-name>, and <string-name><surname>Nathans</surname>, <given-names>J</given-names></string-name>. (<year>1997</year>). <article-title>Essential role of POU-domain factor Brn-3c in auditory and vestibular hair cell development</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>94</volume>, <fpage>9445</fpage>–<lpage>9450</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.17.9445</pub-id>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Zhu</surname>, <given-names>G.J.</given-names></string-name>, <string-name><surname>Gong</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>D.B.</given-names></string-name>, <string-name><surname>Tao</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>W.Q.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Qian</surname>, <given-names>X.Y.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Fan</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal> (<year>2020</year>). <article-title>Aldh inhibitor restores auditory function in a mouse model of human deafness</article-title>. <source>PLoS Genet</source> <volume>16</volume>, <issue>e1009040</issue>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1009040</pub-id>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Erkman</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>McEvilly</surname>, <given-names>R.J.</given-names></string-name>, <string-name><surname>Luo</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Ryan</surname>, <given-names>A.K.</given-names></string-name>, <string-name><surname>Hooshmand</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>O’Connell</surname>, <given-names>S.M.</given-names></string-name>, <string-name><surname>Keithley</surname>, <given-names>E.M.</given-names></string-name>, <string-name><surname>Rapaport</surname>, <given-names>D.H.</given-names></string-name>, <string-name><surname>Ryan</surname>, <given-names>A.F.</given-names></string-name>, and <string-name><surname>Rosenfeld</surname>, <given-names>M.G</given-names></string-name>. (<year>1996</year>). <article-title>Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development</article-title>. <source>Nature</source> <volume>381</volume>, <fpage>603</fpage>–<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1038/381603a0</pub-id>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Xiang</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>W.Q.</given-names></string-name>, <string-name><surname>Hasson</surname>, <given-names>T.</given-names></string-name>, and <string-name><surname>Shin</surname>, <given-names>J.J</given-names></string-name>. (<year>1998</year>). <article-title>Requirement for Brn-3c in maturation and survival, but not in fate determination of inner ear hair cells</article-title>. <source>Development</source> <volume>125</volume>, <fpage>3935</fpage>–<lpage>3946</lpage>. <pub-id pub-id-type="doi">10.1242/dev.125.20.3935</pub-id>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Yu</surname>, <given-names>H.V.</given-names></string-name>, <string-name><surname>Tao</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Llamas</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Nguyen</surname>, <given-names>J.D.</given-names></string-name>, <string-name><surname>Trecek</surname>, <given-names>T.</given-names></string-name>, and <string-name><surname>Segil</surname>, <given-names>N</given-names></string-name>. (<year>2021</year>). <article-title>POU4F3 pioneer activity enables ATOH1 to drive diverse mechanoreceptor differentiation through a feed-forward epigenetic mechanism</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>118</volume>. <pub-id pub-id-type="doi">10.1073/pnas.2105137118</pub-id>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Wallis</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Hamblen</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Venken</surname>, <given-names>K.J.</given-names></string-name>, <string-name><surname>Schumacher</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Grimes</surname>, <given-names>H.L.</given-names></string-name>, <string-name><surname>Zoghbi</surname>, <given-names>H.Y.</given-names></string-name>, <string-name><surname>Orkin</surname>, <given-names>S.H.</given-names></string-name>, and <string-name><surname>Bellen</surname>, <given-names>H.J</given-names></string-name>. (<year>2003</year>). <article-title>The zinc finger transcription factor Gfi1, implicated in lymphomagenesis, is required for inner ear hair cell differentiation and survival</article-title>. <source>Development</source> <volume>130</volume>, <fpage>221</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1242/dev.00190</pub-id>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Hertzano</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Montcouquiol</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Rashi-Elkeles</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Elkon</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Yucel</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Frankel</surname>, <given-names>W.N.</given-names></string-name>, <string-name><surname>Rechavi</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Moroy</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Friedman</surname>, <given-names>T.B.</given-names></string-name>, <string-name><surname>Kelley</surname>, <given-names>M.W.</given-names></string-name>, and <string-name><surname>Avraham</surname>, <given-names>K.B</given-names></string-name>. (<year>2004</year>). <article-title>Transcription profiling of inner ears from Pou4f3(ddl/ddl) identifies Gfi1 as a target of the Pou4f3 deafness gene</article-title>. <source>Hum Mol Genet</source> <volume>13</volume>, <fpage>2143</fpage>–<lpage>2153</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh218</pub-id>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Grifone</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Saquet</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>Z.</given-names></string-name>, and <string-name><surname>Shi</surname>, <given-names>D.L</given-names></string-name>. (<year>2018</year>). <article-title>Expression patterns of Rbm24 in lens, nasal epithelium, and inner ear during mouse embryonic development</article-title>. <source>Dev Dyn</source> <volume>247</volume>, <fpage>1160</fpage>–<lpage>1169</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.24666</pub-id>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>S.</given-names></string-name>, and <string-name><surname>Liu</surname>, <given-names>Z</given-names></string-name>. (<year>2021</year>). <article-title>Mosaic CRISPR-stop enables rapid phenotyping of nonsense mutations in essential genes</article-title>. <source>Development</source>. <pub-id pub-id-type="doi">10.1242/dev.196899</pub-id>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Pan</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wei</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Ying</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Ren</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>G.</given-names></string-name>, <etal>et al.</etal> (<year>2018</year>). <article-title>Simultaneous zygotic inactivation of multiple genes in mouse through CRISPR/Cas9-mediated base editing</article-title>. <source>Development</source> <volume>145</volume>. <pub-id pub-id-type="doi">10.1242/dev.168906</pub-id>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Matern</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Vijayakumar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Margulies</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Milon</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Elkon</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>S.M.</given-names></string-name>, and <string-name><surname>Hertzano</surname>, <given-names>R</given-names></string-name>. (<year>2017</year>). <article-title>Gfi1(Cre) mice have early onset progressive hearing loss and induce recombination in numerous inner ear non-hair cells</article-title>. <source>Sci Rep</source> <volume>7</volume>, <fpage>42079</fpage>. <pub-id pub-id-type="doi">10.1038/srep42079</pub-id>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Yang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Gan</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Xie</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Deng</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Feng</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>Z.</given-names></string-name>, and <string-name><surname>Gan</surname>, <given-names>L</given-names></string-name>. (<year>2010</year>). <article-title>Gfi1-Cre knock-in mouse line: A tool for inner ear hair cell-specific gene deletion</article-title>. <source>Genesis</source> <volume>48</volume>, <fpage>400</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1002/dvg.20632</pub-id>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Matern</surname>, <given-names>M.S.</given-names></string-name>, <string-name><surname>Milon</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Lipford</surname>, <given-names>E.L.</given-names></string-name>, <string-name><surname>McMurray</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ogawa</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Tkaczuk</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Elkon</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>Hertzano</surname>, <given-names>R</given-names></string-name>. (<year>2020</year>). <article-title>GFI1 functions to repress neuronal gene expression in the developing inner ear hair cells</article-title>. <source>Development</source> <volume>147</volume>. <pub-id pub-id-type="doi">10.1242/dev.186015</pub-id>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Kothary</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Clapoff</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Darling</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Perry</surname>, <given-names>M.D.</given-names></string-name>, <string-name><surname>Moran</surname>, <given-names>L.A.</given-names></string-name>, and <string-name><surname>Rossant</surname>, <given-names>J</given-names></string-name>. (<year>1989</year>). <article-title>Inducible expression of an hsp68-lacZ hybrid gene in transgenic mice</article-title>. <source>Development</source> <volume>105</volume>, <fpage>707</fpage>–<lpage>714</lpage>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Jiang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Ramakrishnan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Fritzsch</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>L.</given-names></string-name>, and <string-name><surname>Xu</surname>, <given-names>P.X</given-names></string-name>. (<year>2021</year>). <article-title>Chromatin remodelers and lineage-specific factors interact to target enhancers to establish proneurosensory fate within otic ectoderm</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>118</volume>. <pub-id pub-id-type="doi">10.1073/pnas.2025196118</pub-id>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Shu</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Hong</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Luo</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Du</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Yin</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Yin</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>L.</given-names></string-name>, <etal>et al.</etal> (<year>2022</year>). <article-title>Single-cell chromatin accessibility identifies enhancer networks driving gene expression during spinal cord development in mouse</article-title>. <source>Dev Cell</source> <volume>57</volume>, <fpage>2761</fpage>–<lpage>2775</lpage> e2766. <pub-id pub-id-type="doi">10.1016/j.devcel.2022.11.011</pub-id>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Sun</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>L.</given-names></string-name>, and <string-name><surname>Liu</surname>, <given-names>Z</given-names></string-name>. (<year>2022</year>). <article-title>In vivo CRISPR-Cas9-mediated DNA chop identifies a cochlear outer hair cell-specific enhancer</article-title>. <source>FASEB J</source> <volume>36</volume>, <issue>e22233</issue>. <pub-id pub-id-type="doi">10.1096/fj.202100421RR</pub-id>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Petit</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Bonnet</surname>, <given-names>C.</given-names></string-name>, and <string-name><surname>Safieddine</surname>, <given-names>S</given-names></string-name>. (<year>2023</year>). <article-title>Deafness: from genetic architecture to gene therapy</article-title>. <source>Nat Rev Genet</source>. <pub-id pub-id-type="doi">10.1038/s41576-023-00597-7</pub-id>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Fritzsch</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Matei</surname>, <given-names>V.A.</given-names></string-name>, <string-name><surname>Nichols</surname>, <given-names>D.H.</given-names></string-name>, <string-name><surname>Bermingham</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Beisel</surname>, <given-names>K.W.</given-names></string-name>, and <string-name><surname>Wang</surname>, <given-names>V.Y</given-names></string-name>. (<year>2005</year>). <article-title>Atoh1 null mice show directed afferent fiber growth to undifferentiated ear sensory epithelia followed by incomplete fiber retention</article-title>. <source>Dev Dyn</source> <volume>233</volume>, <fpage>570</fpage>–<lpage>583</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.20370</pub-id>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Atar</surname>, <given-names>O.</given-names></string-name>, and <string-name><surname>Avraham</surname>, <given-names>K.B</given-names></string-name>. (<year>2010</year>). <article-title>Anti-apoptotic factor z-Val-Ala-Asp-fluoromethylketone promotes the survival of cochlear hair cells in a mouse model for human deafness</article-title>. <source>Neuroscience</source> <volume>168</volume>, <fpage>851</fpage>–<lpage>857</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.04.011</pub-id>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Giffen</surname>, <given-names>K.P.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Henderson</surname>, <given-names>H.J.</given-names></string-name>, <string-name><surname>Cao</surname>, <given-names>T.A.</given-names></string-name>, <string-name><surname>Kozeny</surname>, <given-names>G.A.</given-names></string-name>, <string-name><surname>Beisel</surname>, <given-names>K.W.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name>, and <string-name><surname>He</surname>, <given-names>D.Z</given-names></string-name>. (<year>2022</year>). <article-title>Molecular and cytological profiling of biological aging of mouse cochlear inner and outer hair cells</article-title>. <source>Cell Rep</source> <volume>39</volume>, <issue>110665</issue>. <pub-id pub-id-type="doi">10.1016/j.celrep.2022.110665</pub-id>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Sun</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Luo</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Ren</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>G.</given-names></string-name>, and <string-name><surname>Liu</surname>, <given-names>Z</given-names></string-name>. (<year>2021</year>). <article-title>Dual expression of Atoh1 and Ikzf2 promotes transformation of adult cochlear supporting cells into outer hair cells</article-title>. <source>Elife</source> <volume>10</volume>. <pub-id pub-id-type="doi">10.7554/eLife.66547</pub-id>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Ranum</surname>, <given-names>P.T.</given-names></string-name>, <string-name><surname>Goodwin</surname>, <given-names>A.T.</given-names></string-name>, <string-name><surname>Yoshimura</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kolbe</surname>, <given-names>D.L.</given-names></string-name>, <string-name><surname>Walls</surname>, <given-names>W.D.</given-names></string-name>, <string-name><surname>Koh</surname>, <given-names>J.Y.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>D.Z.Z.</given-names></string-name>, and <string-name><surname>Smith</surname>, <given-names>R.J.H</given-names></string-name>. (<year>2019</year>). <article-title>Insights into the Biology of Hearing and Deafness Revealed by Single-Cell RNA Sequencing</article-title>. <source>Cell Rep</source> <volume>26</volume>, <fpage>3160</fpage>–<lpage>3171</lpage> e3163. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.02.053</pub-id>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Peng</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Du</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Xi</surname>, <given-names>Y.</given-names></string-name>, and <string-name><surname>Xu</surname>, <given-names>Z</given-names></string-name>. (<year>2023</year>). <article-title>RBM24 is required for mouse hair cell development through regulating pre-mRNA alternative splicing and mRNA stability</article-title>. <source>J Cell Physiol</source>. <pub-id pub-id-type="doi">10.1002/jcp.31003</pub-id>.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Zheng</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Cai</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Xu</surname>, <given-names>X.Q</given-names></string-name>. (<year>2021</year>). <article-title>Rbm24 regulates inner-ear-specific alternative splicing and is essential for maintaining auditory and motor coordination</article-title>. <source>RNA Biol</source> <volume>18</volume>, <fpage>468</fpage>–<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1080/15476286.2020.1817265</pub-id>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zou</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Hou</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Hu</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal> (<year>2022</year>). <article-title>Template-independent genome editing in the Pcdh15(av-3j) mouse, a model of human DFNB23 nonsyndromic deafness</article-title>. <source>Cell Rep</source> <volume>40</volume>, <issue>111061</issue>. <pub-id pub-id-type="doi">10.1016/j.celrep.2022.111061</pub-id>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Cai</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Jen</surname>, <given-names>H.I.</given-names></string-name>, <string-name><surname>Kang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Klisch</surname>, <given-names>T.J.</given-names></string-name>, <string-name><surname>Zoghbi</surname>, <given-names>H.Y.</given-names></string-name>, and <string-name><surname>Groves</surname>, <given-names>A.K</given-names></string-name>. (<year>2015</year>). <article-title>Characterization of the transcriptome of nascent hair cells and identification of direct targets of the Atoh1 transcription factor</article-title>. <source>J Neurosci</source> <volume>35</volume>, <fpage>5870</fpage>–<lpage>5883</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5083-14.2015</pub-id>.</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Fiolka</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Hertzano</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Vassen</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zeng</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Hermesh</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Avraham</surname>, <given-names>K.B.</given-names></string-name>, <string-name><surname>Duhrsen</surname>, <given-names>U.</given-names></string-name>, and <string-name><surname>Moroy</surname>, <given-names>T</given-names></string-name>. (<year>2006</year>). <article-title>Gfi1 and Gfi1b act equivalently in haematopoiesis, but have distinct, non-overlapping functions in inner ear development</article-title>. <source>EMBO Rep</source> <volume>7</volume>, <fpage>326</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1038/sj.embor.7400618</pub-id>.</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Tornari</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Towers</surname>, <given-names>E.R.</given-names></string-name>, <string-name><surname>Gale</surname>, <given-names>J.E.</given-names></string-name>, and <string-name><surname>Dawson</surname>, <given-names>S.J</given-names></string-name>. (<year>2014</year>). <article-title>Regulation of the orphan nuclear receptor Nr2f2 by the DFNA15 deafness gene Pou4f3</article-title>. <source>PLoS One</source> <volume>9</volume>, <issue>e112247</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0112247</pub-id>.</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Towers</surname>, <given-names>E.R.</given-names></string-name>, <string-name><surname>Kelly</surname>, <given-names>J.J.</given-names></string-name>, <string-name><surname>Sud</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Gale</surname>, <given-names>J.E.</given-names></string-name>, and <string-name><surname>Dawson</surname>, <given-names>S.J</given-names></string-name>. (<year>2011</year>). <article-title>Caprin-1 is a target of the deafness gene Pou4f3 and is recruited to stress granules in cochlear hair cells in response to ototoxic damage</article-title>. <source>J Cell Sci</source> <volume>124</volume>, <fpage>1145</fpage>–<lpage>1155</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.076141</pub-id>.</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Akil</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Dyka</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Calvet</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Emptoz</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lahlou</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Nouaille</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>Boutet</given-names> <surname>de Monvel</surname></string-name>, <string-name><given-names>J.</given-names>, <surname>Hardelin</surname></string-name>, <string-name><given-names>J.P.</given-names>, <surname>Hauswirth</surname></string-name>, <string-name><given-names>W.W.</given-names>, <surname>Avan</surname></string-name>, <string-name><given-names>P.</given-names>, <surname>et al</surname></string-name>. (<year>2019</year>). <article-title>Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>116</volume>, <fpage>4496</fpage>–<lpage>4501</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1817537116</pub-id>.</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Tang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Hu</surname>, <given-names>S.W.</given-names></string-name>, <string-name><surname>Lv</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Xun</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>D.</given-names></string-name>, <etal>et al.</etal> (<year>2023</year>). <article-title>Hearing of Otof-deficient mice restored by trans-splicing of N- and C-terminal otoferlin</article-title>. <source>Hum Genet</source> <volume>142</volume>, <fpage>289</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-022-02504-2</pub-id>.</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Al-Moyed</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Cepeda</surname>, <given-names>A.P.</given-names></string-name>, <string-name><surname>Jung</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Moser</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kugler</surname>, <given-names>S.</given-names></string-name>, and <string-name><surname>Reisinger</surname>, <given-names>E</given-names></string-name>. (<year>2019</year>). <article-title>A dual-AAV approach restores fast exocytosis and partially rescues auditory function in deaf otoferlin knock-out mice</article-title>. <source>EMBO Mol Med</source> <volume>11</volume>. <pub-id pub-id-type="doi">10.15252/emmm.201809396</pub-id>.</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Akil</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Seal</surname>, <given-names>R.P.</given-names></string-name>, <string-name><surname>Burke</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Alemi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>During</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Edwards</surname>, <given-names>R.H.</given-names></string-name>, and <string-name><surname>Lustig</surname>, <given-names>L.R</given-names></string-name>. (<year>2012</year>). <article-title>Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy</article-title>. <source>Neuron</source> <volume>75</volume>, <fpage>283</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.05.019</pub-id>.</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Tan</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Chu</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Qi</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>You</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>X.</given-names></string-name>, <etal>et al.</etal> (<year>2019</year>). <article-title>AAV-ie enables safe and efficient gene transfer to inner ear cells</article-title>. <source>Nat Commun</source> <volume>10</volume>, <fpage>3733</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-11687-8</pub-id>.</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Wu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Solanes</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Nist-Lund</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Spataro</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Shubina-Oleinik</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Marcovich</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Goldberg</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Schneider</surname>, <given-names>B.L.</given-names></string-name>, and <string-name><surname>Holt</surname>, <given-names>J.R</given-names></string-name>. (<year>2021</year>). <article-title>Single and Dual Vector Gene Therapy with AAV9-PHP</article-title>.<source>B Rescues Hearing in Tmc1 Mutant Mice. Mol Ther</source> <volume>29</volume>, <fpage>973</fpage>–<lpage>988</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymthe.2020.11.016</pub-id>.</mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Isgrig</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>McDougald</surname>, <given-names>D.S.</given-names></string-name>, <string-name><surname>Zhu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.J.</given-names></string-name>, <string-name><surname>Bennett</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Chien</surname>, <given-names>W.W</given-names></string-name>. (<year>2019</year>). <article-title>AAV2.7m8 is a powerful viral vector for inner ear gene therapy</article-title>. <source>Nat Commun</source> <volume>10</volume>, <issue>427</issue>. <pub-id pub-id-type="doi">10.1038/s41467-018-08243-1</pub-id>.</mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Landegger</surname>, <given-names>L.D.</given-names></string-name>, <string-name><surname>Pan</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Askew</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wassmer</surname>, <given-names>S.J.</given-names></string-name>, <string-name><surname>Gluck</surname>, <given-names>S.D.</given-names></string-name>, <string-name><surname>Galvin</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Taylor</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Forge</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Stankovic</surname>, <given-names>K.M.</given-names></string-name>, <string-name><surname>Holt</surname>, <given-names>J.R.</given-names></string-name>, and <string-name><surname>Vandenberghe</surname>, <given-names>L.H</given-names></string-name>. (<year>2017</year>). <article-title>A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear</article-title>. <source>Nat Biotechnol</source> <volume>35</volume>, <fpage>280</fpage>–<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3781</pub-id>.</mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Shu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>L.</given-names></string-name>, and <string-name><surname>Liu</surname>, <given-names>Z</given-names></string-name>. (<year>2018</year>). <article-title>Characterizing a novel vGlut3-P2A-iCreER knockin mouse strain in cochlea</article-title>. <source>Hear Res</source> <volume>364</volume>, <fpage>12</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.heares.2018.04.006</pub-id>.</mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Owen</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>L.</given-names></string-name>, and <string-name><surname>Zuo</surname>, <given-names>J</given-names></string-name>. (<year>2010</year>). <article-title>Dynamic expression pattern of Sonic hedgehog in developing cochlear spiral ganglion neurons</article-title>. <source>Dev Dyn</source> <volume>239</volume>, <fpage>1674</fpage>–<lpage>1683</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.22302</pub-id>.</mixed-citation></ref>
</ref-list>
<sec id="s5">
<title>Supplemental Figure Legends</title>
<p><fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 1.</label>
<caption><title>Rbm24 expression is repressed in cochlear HCs at E16.5 when Pou4f3 is inactivated.</title>
<p><bold>(A)</bold> An illustration of how <italic>Pou4f3<sup>-/-</sup></italic> mice (Founder 0, F0) were rapidly generated by CRISPR-stop. <bold>(B-C)</bold> Sanger sequencing chromatograms of WT (B) and F0 <italic>Pou4f3<sup>-/-</sup></italic> (C) were presented. The base ‘C’ (black arrow in B) was completely converted to ‘T’ (red arrow in C), resulting in pre-emergence of protein translation stop codon. The <italic>Pou4f3<sup>-/-</sup></italic>mutants (F0 mice) were immediately ready for phenotypic analysis. <bold>(D-E’’’)</bold> Triple staining of pan-HC marker Pou4f3, Rbm24 and OHC marker Insm1 in whole mount prepared cochlear samples (basal turns) of WT (D-D’’’, n=3) and <italic>Pou4f3<sup>-/-</sup></italic> (E-E’’’, n=9) at E16.5. Relative to WT mice, both Pou4f3 and Rbm24 expression disappeared in <italic>Pou4f3<sup>-/-</sup></italic> HCs, whereas the Insm1 expression was normal. The orange arrows in (E-E’’’) pointed to one Insm1+ OHC that lost Pou4f3 and Rbm24. OHC: outer hair cell; IHC: inner hair cell. Scale bar: 20 μm (E’’’).</p></caption>
<graphic xlink:href="546097v1_figs1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 2.</label>
<caption><title>Severe degeneration of <italic>Pou4f3<sup>-/-</sup></italic> HCs happens by perinatal ages.</title><p><bold>(A-C’’)</bold> Dual staining of Pou4f3 and Myo7a in middle turn regions of the cochleae of WT (A-A’’) at P1 and <italic>Pou4f3<sup>-/-</sup></italic> mice at P0 (B-B’’) and at P1 (C-C’’). Notably, here the <italic>Pou4f3<sup>-/-</sup></italic> mice were germ line stable strain produced by CRISPR/Cas9-mediated large DNA fragment deletion (<xref rid="fig1" ref-type="fig">Figure 1A</xref>). Arrows in (B-C’’) represented the surviving HCs in the absence of Pou4f3. <bold>(D)</bold> Quantification of the percentage of the remaining HCs at basal, middle, and apical turns in <italic>Pou4f3<sup>-/-</sup></italic> mice at P0 (n=4) or at P1 (n=3), relative to WT mice at P1 (n=3). Data were presented as Mean ± Sem. Student’s <italic>t</italic> test was used for statistical analysis. ** p&lt;0.01; **** p&lt;0.0001; n.s. no significant difference. HC degeneration at middle and basal turns was more severe at P1 than that at P0, but there was no significant difference in apical turns (D). <bold>(E-F’’)</bold> Dual staining of Rbm24 and Myo7a in WT (E-E’’, n=3) and <italic>Pou4f3<sup>-/-</sup></italic> (F-F’’, n=3) mice at P1. The white arrow in (F-F’’) marked one remaining <italic>Pou4f3<sup>-/-</sup></italic> HC that lost Rbm24 expression. OHC: outer hair cell; IHC: inner hair cell; HC: hair cell. Scale bar: 20 μm (C’’ and F’’).</p></caption>
<graphic xlink:href="546097v1_figs2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs3" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 3.</label>
<caption><title>Construction of <italic>Gfi1-3◊HA-P2A-Cre/+</italic> (<italic>Gfi1<sup>HA-Cre/+</sup></italic>) mouse model by which HA can faithfully represent Gfi1 expression.</title>
<p>(<bold>A-C</bold>) A simple cartoon to illustrate how the <italic>Gfi1<sup>HA-Cre/+</sup></italic> strain was constructed. Basically, the WT Gfi1 allele (A) was inserted a fragment containing 3◊HA-P2A-Cre (B) immediately before the TGA stop codon (red in A), resulting in a post-targeted <italic>Gfi1<sup>HA-Cre/+</sup></italic> allele (C). <bold>(D)</bold> One exampled tail PCR gel image that helped us to distinguish <italic>Gfi1<sup>+/+</sup>, Gfi1<sup>HA-Cre/+</sup></italic> and <italic>Gfi1<sup>HA-Cre/HA-Cre</sup></italic> mice. <bold>(E-F’’)</bold> Dual staining of HA (Gfi1) and HC marker Myo7a of control <italic>Gfi1<sup>+/+</sup></italic> (E-E’’, n=3) and homozygous <italic>Gfi1<sup>HA-Cre/HA-Cre</sup></italic>mice (F-F’’, n=3) at P1. Arrows in (F-F’’) marked one OHC that expressed HA (Gfi1) and Myo7a. <bold>(G-J’’)</bold> Fate mapping analysis of cells experiencing <italic>Gfi1</italic> expression by <italic>Gfi1<sup>HA-Cre/+</sup>; Rosa26-loxp-stop-loxp-tdTomato</italic> (Ai9)<italic>/+</italic> (<italic>Gfi1<sup>HA-Cre/+</sup></italic>; Ai9/+), with confocal low magnification images being presented in (G-H’’’) and high magnification images in (I-J’’). In Ai9/+ control mice at P2 (n=5), no Tdtomato+ cells were detected (G-G’’’ and I-I’’). In contrast, in the <italic>Gfi1<sup>HA-Cre/+</sup></italic>; Ai9/+ mice (n=5), Tdtomato was detected in both non-sensory cells (white arrows in H) and the Myo7a+ HCs that expressed heterogeneous levels of HA (Gfi1), as represented in different arrows in (J-J’’): white arrows (#1) marked one OHC with the highest HA (Gfi1), the orange arrows (#3) with the lowest (or undetectable) HA (Gfi1), and the blue arrows (#2) with the intermediate level of HA (Gfi1). Scale bars: 100μm in (H’’’); 20 μm (F’’ and J’’).</p></caption>
<graphic xlink:href="546097v1_figs3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs4" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 4.</label>
<caption><title>Gfi1 expression is lost in the <italic>Pou4f3</italic><sup>-/-</sup> HCs.</title>
<p><bold>(A)</bold> One-step generation of <italic>Pou4f3</italic> mutants by CRISPR-stop, with the zygotes derived from the <italic>Gfi1<sup>HA-Cre/+</sup></italic> mice. <bold>(B-C)</bold> Sanger sequencing chromatograms of tail DNA from the control <italic>Gfi1<sup>HA-Cre/+</sup></italic> (B) and <italic>Gfi1<sup>HA-Cre/+</sup>; Pou4f3<sup>-/-</sup></italic> (mosaic) mice (C). The base ‘C’ in (blue arrow in B) was converted to ‘T’ (red arrow in C). However, the conversion was not complete because double peak existed, supporting that the inactivation of <italic>Pou4f3</italic> was mosaic. <bold>(D-E’’’)</bold> Triple staining of Pou4f3, Rbm24 and HA (Gfi1) in the basal region of cochleae of <italic>Gfi1<sup>HA-Cre/+</sup></italic> (D-D’’’, n=3) and <italic>Gfi1<sup>HA-Cre/+</sup>; Pou4f3<sup>-/-</sup></italic>(mosaic, E-E’’’, n=3) at E16.5. Blue arrows in (E-E’’’) marked one OHC that expressed Pou4f3, Rbm24 and HA (Gfi1), whereas the orange arrows labelled the other OHC that lost Pou4f3, Rbm24 and HA (Gfi1). Thus, it confirmed that not only HA faithfully represented the Gfi1 expression, but also HA expression was dependent on Pou4f3. Scale bar: 20 μm (E’’’).</p></caption>
<graphic xlink:href="546097v1_figs4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs5" position="float" orientation="portrait" fig-type="figure">
<label>Supplemental Figure 5.</label>
<caption><title>Rbm24 expression is normal in the absence of <italic>Gfi1</italic>.</title>
<p><bold>(A)</bold> The DNA fragment between the sgRNA-4 and sgRNA-9 within the <italic>Gfi1</italic> locus was deleted by CRISPR/Cas9 method. <bold>(B)</bold> One exampled tail PCR gel image that helped us to distinguish <italic>Gfi1<sup>+/+</sup>, Gfi1<sup>+/-</sup></italic> and <italic>Gfi1<sup>-/-</sup></italic> mice. <bold>(C-D’’)</bold> Dual staining of Pou4f3 and Rbm24 in middle turn cochleae of WT (C-C’’, n=3) and <italic>Gfi1<sup>-/-</sup></italic>(D-D’’, n=3) at P1. Severe HC, especially OHC, degeneration happened in <italic>Gfi1<sup>-/-</sup></italic> cochleae. The orange arrows in (D-D’’) marked one surviving <italic>Gfi1<sup>-/-</sup></italic> OHC that expressed Pou4f3 and Rbm24. <bold>(E-F’’’)</bold> Triple staining of Pou4f3, Rbm24 and OHC marker Bcl11b of cochleae of WT (E-E’’’, n=3) and <italic>Gfi1<sup>-/-</sup></italic> (F-F’’’, n=3) at E16.5. In terms of the expression patterns of Pou4f3, Rbm24 and Bcl11b, no significant difference was captured between WT and <italic>Gfi1<sup>-/-</sup></italic> cochleae at E16.5, suggesting that <italic>Gfi1<sup>-/-</sup></italic> HC degeneration did not start yet. Scale bars: 20 μm (D’’ and F’’’).</p></caption>
<graphic xlink:href="546097v1_figs5.tif" mimetype="image" mime-subtype="tiff"/>
</fig></p></sec></back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.90025.1.sa2</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Whitfield</surname>
<given-names>Tanya T</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>University of Sheffield</institution>
</institution-wrap>
<city>Sheffield</city>
<country>United Kingdom</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Compelling</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Useful</kwd>
</kwd-group>
</front-stub>
<body>
<p>In this <bold>useful</bold> study, the authors explore regulatory cascades governing mammalian cochlear hair cell development and survival. They confirm previous studies that the transcription factors Pou4f3 and Gfi1 are necessary for hair cell survival, and use <bold>compelling</bold> evidence to demonstrate that the RNA binding protein gene RBM24 is regulated by Pou4f3, but not Gfi1. These findings will be of interest to those working on hearing loss, and hold significance for viral gene delivery methods aiming to manipulate gene expression.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.90025.1.sa1</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Wang and colleagues recently demonstrated the essential role of RBM24 (RNA-binding motif protein 24a) in the development of mouse hair cells (source: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jcp.31003">https://doi.org/10.1002/jcp.31003</ext-link>). In this study, they further expand on their findings by revealing that Rbm24 expression is absent in Pou4f3 mutant mice but not in Gfi1 mutant mice. This observation suggests that POU4F3 acts as an upstream regulator of Rbm24. The researchers effectively demonstrate that POU4F3 can bind to and regulate Rbm24 through three distant enhancers, which are located in open chromatin regions and are bound by POU4F3. Lastly, Wang and colleagues discovered that ectopic expression of Rbm24 was unable to prevent the degeneration of POU4F3 null hair cells.</p>
<p>The findings in this manuscript hold great significance as they provide additional insights into the transcriptional cascades crucial for hair cell development. The discovery of enhancers capable of driving transgene expression specifically in hair cells holds promising therapeutic implications. The figures presented in the study are of excellent quality, the employed techniques are state-of-the-art, the data are accurately represented without exaggeration, and the study demonstrates a high level of rigor.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.90025.1.sa0</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Previous studies have shown that two hair cell transcription factors, Pou4f3 and Gfi1, are both necessary for the survival of cochlear hair cells, and that Gfi1 is regulated by Pou4f3. The authors have previously also shown that mosaic inactivation of the RNA-binding protein RBM24 leads to outer hair cell death.</p>
<p>In the present study, the authors show that hair cells die in Pou4f3 and Gfi1 mutant mice. They show that Gfi1 is regulated by Pou4f3. Both these observations have been published before. They then show that RBM24 is absent in Pou4f3 knockouts, but not Gfi1 knockouts. They ectopically activate RMB24 in the hair cells of Pou4f3 knockouts, but this does not rescue the hair cell death. Finally, the authors validate three RMB24 enhancers that are active in young hair cells and which have been previously shown to bind Pou4f3.</p>
<p>The experiments are well-executed and the data are clear. The results support the conclusions of the paper.</p>
<p>Much of the work in the paper has been reported before. The result that hair cell transcription factors operate in a network, with some transcription factors activating only a subset of hair cell genes, is an expected result. Since RMB24 is only one of many genes regulated directly by Pou4f3, it is not surprising that it cannot rescue the Pou4f3 knockout hair cell degeneration.</p>
<p>The identification of new hair cell enhancers may be of use to investigators wishing to express genes in hair cells.</p>
<p>In sum, this work, although carefully performed, does not shed significant new light on our understanding of hair cell development or survival.</p>
</body>
</sub-article>
</article>